April 2007 - Volume 1, Issue 2

TOWARD MAKING PREGANCY SAFER


Dr. Thamer Kadum Yousif Al Hilfy
MBChB/DCM/FICMS
JMHPE/MsC/Member/medical education
Director Health For All Center (NGO) / Iraq-Baghdad
Assistant Professor / Alkindy College of Medicine/Baghdad

Tel. +96417721963
+9647703459903
Mobile. +9647901734108
E-mail: thamer_sindibaad@yahoo.com
thamer_center2005@yahoo.com

ABSTRACT

Background: This study was carried out in an attempt to demonstrate the epidemiology of safe pregnancy outcome in Iraq. Safe pregnancy is defined as the period encompassing pregnancy, childbirth and the postpartum, which is experienced without complications for both the mother and the fetus/baby.

Methodology: The current work represents an observational longitudinal study, which included (2080) cases of all pregnant women who terminated their pregnancy by delivery, abortion or ectopic pregnancy, or within (42) days after termination of pregnancy, who attended gynecological, obstetrical wards, outpatient clinic and the reproductive health center (family planning clinic) in Tikrit Teaching hospital for the period between the first of November to the end of April (2006). A direct interview was done with every woman; special questionnaire and a physical examination was conducted only for women and their babies included in our study, and investigations done when needed.

Results: It had been found that of the total (2080) women, (1060, 51%) had a safe pregnancy outcome for both mother and her fetus/newborn, and (1020, 49%) had unsafe outcomes either for mother or her fetus/newborn. The total sample was also classified into four groups according to safety of mothers and babies, to make results more accurate. These groups included safe pregnancy outcome for both mother and her fetus/newborn, unsafe outcome for both, safe mother outcome and unsafe fetus/newborn outcome, and unsafe mothers with safe fetus/newborn outcome. The total number of each group of previous groups of mothers and fetuses/newborns, differed from table to table, or figure to another according to their relationship with other variables. The study also determined the rate of perinatal, and maternal mortality, and its causes.

The results showed that, there were many maternal related factors affecting pregnancy outcome that included adolescent mothers, uneducated (not able to read and write) women, grandmultiparas, and women who had broken marital relations (mostly separated) associated with unsafe pregnancy outcome.

Rural residence had been associated with unsafe pregnancy outcomes. The study found that, consanguineous marriage (second degree relative) was associated with unsafe pregnancy outcomes.

Fetal related factors had an effect on pregnancy safety. Single fetus pregnancy, normal newborn birth weight (2500-4000) gm was associated more with safe pregnancy outcome.

Good antenatal care of mothers was associated with safe pregnancy outcome, particularly in those women who attended both private doctor's clinic and primary health care center.

Women who received tetanus toxoid immunization completely, and who spaced their pregnancies more than two years apart, had safer pregnancy outcomes.

The women who completed (37-42) weeks of gestation, with hospital delivery, beside intrapartum regular fetal heart monitoring, and labor within normal duration had been associated with safe pregnancy outcomes.

Rh incompatibility problems between mother and fetus/newborn, bad obstetrical history, positive medical and gynecological and obstetrical surgical problems of mothers had been associated with maternal and fetal/newborn complications.

Conclusion and Recommendations: We concluded from this study that, maternal complications are more frequent in the ante partum period, while fetal complications happened more in the post partum period.

Regarding the perinatal morbidity and mortality, predisposing factors had been related mostly to maternal causes.

About maternal deaths, the study found that most of deaths occurred in the first 42 postpartum days due to direct causes related to pregnancy. The critical issue of maternal mortality encourages us to compare our results with other corresponding studies in the world, and then ratios and the major causes of maternal mortality were determined.

We recommended improvement of maternal health, and neonatal health. This could be achieved by serious cooperation between community (general population), health institutions and their staff.

INTRODUCTION

Every year about (210) million become pregnant in the world (1). Every minute of every day, somewhere in the world and most often in a developing country, a woman dies from complications related to pregnancy or childbirth. That is (515,000) women, at the minimum, die every year. Nearly all maternal deaths (99%) occur in the developing world (2).

For every woman who dies, 30 to 50 women suffer injury, infection, or disease. Pregnancy related complications are among the leading causes of death and disability for women aged 15-49 in developing countries. When a mother dies, children lose their primary caregiver, communities are denied her paid and unpaid labor, and countries forego her contributions to economic and social development. A woman's death is more than personal tragedy; it represents an enormous cost to her nation, her community, and her family. Any social and economic investment that has been made in her life is lost. Her family loses her love, her nurturing, and her productivity inside and outside the home (2).

In developing countries, women's risk of dying, from pregnancy related disorders is on average about 250 times greater than women in most developed countries(1).

In the world more than 70% of maternal deaths are caused by just five conditions: bleeding after delivery - 25% of deaths, infection after delivery - 15%, unsafe abortion - 13%, hypertensive disorders - 12%, obstructed labor - 8%. In addition, about 20% of maternal deaths are due to diseases that are aggravated by pregnancy such as cardiovascular diseases, chronic anemia, gynecological infections, pyelonephritis, chronic renal diseases, malaria, fistulas, uterine prolapse, chronic pelvic pain, and depression also affect large numbers of women (1).

More than a decade of research has shown that small and affordable measures can significantly reduce the health risks that women face when they become pregnant. Most maternal deaths could be prevented if women had access to appropriate health care during pregnancy, childbirth, and immediately afterwards (2).

In Iraq health statistics, the population of Iraq during 2002 was estimated to be 5,565,000 with an urban: rural ratio of 67:33 .The childbearing age women (6.064.000). The health indicators for Iraq are as follows: Maternal mortality ratio is 294/100,000 live births. The percentage of pregnancies at risk is 37.8%. The total fertility rate for Iraqi women is 6% and contraceptive use is 32%. The estimated lifetime risk of maternal death of women in Iraq is 1 in 57. The literacy rate for Iraqi women is 74%. The proportion of maternal deaths taking place during the puerperium is 49%. The main causes of maternal deaths are bleeding (46.4%), followed by acute pulmonary embolism (11.9%), hypertension (8.3%), abortion complications (5.7%), sudden death and irreversible shock (2.3% each), sepsis and obstructed labor (1.1%) (3).

In Salah Al-Deen governorate about 292,000 women are at reproductive age, and the maternal mortality ratio in the governorate is about 29 per 100,000 live births. The most common causes of maternal death were hypertensive disorders, hemorrhage, and midwives' interference (4).

Many of the causes of maternal deaths and disabilities also jeopardize the survival and health of newborn infants (1). Every year in the world nearly 4 million newborn babies die during the first month of life, an additional 4 million are stillborn (2), and millions more are disabled because of inadequately managed pregnancies and deliveries, and because of women's poor health and poor nutritional status. Neonatal infection accounts for 33% of deaths in newborn babies; asphyxia and trauma at birth account for 28%, premature delivery and low birth weight account for 24%, and congenital anomalies around 10% (1), while about 40%-80% of cases of newborn death were due to low birth weight (2).

Newborn health and survival are closely linked to the health of the mother before and during pregnancy, as well as during labor, childbirth, and the postpartum period. Key interventions or improving mother and newborn health include ensuring that all women receive effective, affordable, accessible, and acceptable maternity care (2).

In Iraq, health statistics record that neonatal mortality rate is 67/1000 live births, and the prevalence of low birth weight is 23.1% (3).

In Salah Al-Deen governorate the prenatal mortality ratio was 257 per 100 000 live births(4).
In Tikrit General Teaching Hospital, the statistical records were incorrect and not accurate because of insufficient records supplied by the health office. Regarding 2005, recorded maternal mortality number was only 3, while the perinatal mortality is not recorded and neonatal death is recorded as infant mortality (5).
AIM

The aim of this study is to contribute to achieving of safe pregnancy outcomes among Iraqi childbearing women.
OBJECTIVES

The study is conducted to:

  1. Identify effective practices that could improve maternal and neonatal health.
  2. To recognize the extent and major determinants of maternal mortality and morbidity.
  3. To assess the effect of abortion, delivery site, duration of labor and maternal RH on mothers safety.
  4. To estimate fetal monitoring during pregnancy and labor.
  5. To describe causes of maternal death.
SUBJECTS AND METHODS

Design of the study:
The current work represents an observational longitudinal study, which was conducted from 1st November 2005 to April 2006, and within regular working hours. The study design suited the purpose of this research, and is feasible both from financial as well as technical points of view.

Socio-Demographic characteristics:
The study was conducted in Tikrit General Teaching Hospital, which represents one of the biggest centers located in the center of Tikrit city, which serves a large proportion of the community from different sectors of Salah Al Deen.

Salah Al-Deen Governorate has an estimated population of 1,162,490 persons; Tikrit city represents 159,721 of the population. About 292,000 females or 20% of Salah Al-Deen population, are females at reproduction age (15-49 years old).

The study groups:
Sampling population:
Our sample included all females who attended Tikrit General Teaching Hospital for delivery (pre term, term or post term), abortion, ectopic, or attending for contraceptive advice, check up, or for treatment of any complications, within 42 days of termination of pregnancy, and who attended from the first of November 2005 to the end of April 2006. This includes 2080 pregnant women. Those females were followed in the gynecological and obstetrical wards, outpatient clinic of gynecology and obstetrics, and family planning clinic.
The total sample was classified into four groups which includes the following:

Safe mother and fetus outcome (newborn), unsafe outcome for both mother and fetus, safe mother outcome with unsafe outcome regarding fetus/newborn and the last group is safe fetal/newborn outcome with unsafe outcome regarding the pregnant women. This classification was introduced for the sake of more accurate results.

Our results were compared with three major studies dealing with same concerns. A meta analytic approach was used to study some common variables mainly the maternal mortality ratio (women who died within 42 days postpartum due to direct and indirect causes related to pregnancy).

The total sample size chosen is considered to be suitable in this design study for showing the expected degree of differences regarding different variables. It is known that the sample size had an inverse relationship with alpha error.

As regards the power of the study it is acceptable to use 0.8(80%), as this will guarantee, as we believe that B error will have a limited effect at this level (accepting the null hypothesis when it is false) .

Pilot study and preset:
The real benefit of a pilot study in this research is its usefulness as a pretest measure, done on small scale, to identify any area of ambiguity or weakness related to the research design and tools, besides the acceptability of the community and subjects of the study sample to the research. A small scale pilot study was carried out on a sample of 30 cases and included women pregnant, delivered, and aborted. This pilot study was run for 3 weeks before the study was launched. The consent of those participating in the study was also tested to ensure the clarity of the language and to give an indirect idea about the acceptability of the sampling population.

We did look for any possibility of error and tried to correct it from the beginning as part of quality control measures. Thus quality checks will be set at each state of data collection.
Another seminar was made in the Community Medicine Department in Tikrit College of Medicine, in the presence of the chairman of the department and postgraduate students of the college.
Discussion was made, and comments, notes and suggestions were given by the audience, which were very worthy, and helped much in conducting the final study in a more perfect and practical way.

Development of Questionnaire and Data Collection:
The questionnaire was developed to collect all the data relevant to socio-economic class, and all variables listed below using structured interviewing and simple questionnaire. The interviewing here has the advantages of both the questionnaire and the observation. The response of the study sample was high and was suitable even for illiterates. The possibility of a skewing effect is not high since the required data are not critical to the interviewee, and ethical issues relating to the questions were considered. All questions were to be part of the interview. Issues of confidentiality were foremost and checking on data entry is done on a regular basis.

Age:
It included five age groups (<16, 16-25, 26-35, 36-45, >45) years old.
Occupation.
Marital status.
Residency.
Rh of both parents and baby, which is very important when the mother is Rh negative and the father is Rh positive.
Degree of consanguinity between parents.

Points related to ANC at antenatal period of women include:
Parity: (Zero), (1-4), (=5) babies delivered after 24th weeks of gestation.
Gravida.
Abortion.
Last menstrual period to determine gestational age, and expected delivery date.
ANC was performed with adequate visits or not, and where (private, PHCC, or both).
Immunization: Tetanus toxoid if received by pregnant women completed, or not.
Risky mothers determined with level of risk and its causes.
Any complication during this period.
Termination of pregnancy, abortion and its type, ectopic pregnancy, or stillbirth at which gestational age, causes, and complications.
Intra-partum period
Labor: Full term, preterm, post term.
Site of delivery: Hospital, home.
Duration of labor.
Type of fetal monitoring in the intrapartum period.
Type of delivery: Spontaneous vaginal delivery, normal vaginal delivery with induction, C/S, or instrumental.
Complication during this period (mother, baby).
Number of babies, gender and weight of baby.
Postpartum complications (early, late).

Subjects and Methods
Past obstetrical history:
Number of previous pregnancies.
Outcome of previous pregnancies.
Type of delivery.
Effect of ANC and PNC.
Spacing: It calculated average birth spacing among all pregnancies. Birth spacing less than 2 years, or more than 2 years.
Contraception use and type .
Drug history for:
Preconception preventive drugs.
Specific diseases.
Regarding pregnancy.
Medical history: Cardiovascular diseases, diabetes mellitus, blood diseases, renal diseases and others.
Surgical history: Pelvic (gynecological, obstetrical, or non gynecological), and others.
Social history: Smoking, alcohol, illicit drugs.
Family history: Chronic diseases, multiple pregnancy, hereditary diseases, congenital anomalies.

Examination:
Clinical assessment for every woman who was at ante-partum, intra-partum, and post-partum period, and her neonates.
Blood pressure.
Abdominal examination (fundal level at ante-partum, and post-partum periods).
Mother weight and height.
Fetal heart rate monitoring.
Weight of baby.
APGAR score of baby at first 5 minutes.
Per vaginal examination.

Statistical analysis:
Our study is a cross sectional study, and we will describe the characteristics of the sample choosing the methods of analysis depending on the type of data, whether qualitative or quantitative.

Most of our results are of a qualitative nature and so using chi square to test any significance, will be of benefit.

Several descriptions to explore our analysis were used and were not restricted to table presentation, whether percentages or frequency distribution but also including graphic presentation as a `Bar chart' as we are dealing here with qualitative data.

The data collected on 2080 women were included in the study to assess the association of many risk factors with safe outcome (for the mother and the baby).

So conventional statistical techniques were applied to the data in the study of distribution by frequency percentage, tables, and graph presentations. Considering the level of significance for this study is 0.05 for the sake of minimizing alpha error (rejecting the null hypothesis when it is true).

Statistical analysis was done using the new version of Minitab package/2006.
RESULTS

The total sample studied in this research was 2080 women who were pregnant then terminated their pregnancy, or within 42 days of termination, and attended the hospital. In general regarding the outcome including the mothers and babies 1060, (51%) were classified as safe pregnancy outcome, and 1020, (49%) as unsafe pregnancy outcome. The number of safe mothers was 1257, and unsafe mothers 823, but after exclusion of abortion and ectopic pregnancy the number of safe mothers became 1180 and unsafe mothers 780. The number of safe babies was 1680, and unsafe babies 400, but after exclusion of abortion (118) and ectopic pregnancy (2) the remaining unsafe babies were 280. Both mothers and babies were safe (1060), both unsafe (160), safe mothers and unsafe babies (120), unsafe mothers and safe babies (620), the number of twins (80) babies, except for abortion and ectopic pregnancy.

Regarding the maternal age the study showed that, those who had safe pregnancy outcome were aged 16-25 years, and their number was 518 (56.4%), and those who had unsafe pregnancy outcomes where at the age <16 and their number 40 (95.2 %). Table (1)The study demonstrated the association between maternal educational level and outcome in that 728 (76%) of safe pregnancy outcomes were of literate women, while regarding the unsafe pregnancy outcome 790 (70.4%) were illiterate women. Table (1)

Regarding the relationship between parity and pregnancy outcomes, the study showed that, 523 (56.4%) of safe pregnancies were in (1-4) of the parity group. While 166 (62.9%) of unsafe pregnancy outcomes were in (=5) parity group. Table (1) The study showed that 1054 (54.1%) of safe outcomes were in married women, but most of the unsafe outcomes were in separated women and their number was 76 (96.2%). Table (1)

Regarding the fetal and maternal safety in relation to number of fetuses, total fetuses were 2040 after exclusion of abortion and ectopic, and inclusion of twins. Among single fetuses pregnancy, 1068 (54.5%) had a safe outcome. But among multiple fetuses pregnancy, 13 (16.2%) had safe pregnancy outcomes. Table (2)

Regarding the gender, the total (2040) and the study showed that, equal effect of both male and female gender on safety of pregnancy outcome, 540 (53%) of males and 541 (53%) of females had a safe pregnancy outcome. Table (2)

Regarding weight of babies, the study demonstrated 3 (100%) of babies with extreme low birth weight [<1000] gm had unsafe pregnancy outcomes. While 74 (100%) of babies with very low birth weight [<1500] gm had unsafe pregnancy outcomes. 134 (100%) with low birth weight [<2500] gm, also had unsafe pregnancy outcomes. But 1080 (61.3%) of normal birth weight [2500-4000] gm had safe pregnancy outcomes, while 1 (1.5%) of macrosomic babies with weight [>4000] had safe pregnancy outcomes.

Regarding residency distribution, the study showed that, 674 (65.7%) of safe outcomes were living in urban areas, while 386 (36.6%) of safe outcomes lived in rural areas. Figure (1)

Regarding the degree of parental consanguinity, the study showed that, 104 (8.5%) of non-related couples had unsafe pregnancy outcomes, while 126 (45.7%) in second degree relative couples had unsafe pregnancy outcomes. Figure (2)

The study showed that, 939 (68.9%) of safe pregnancy outcomes had good antenatal care (=5visits), while 13 (12.6%) of safe outcomes had no antenatal care at all. Table (3)

After referring to ANC visit and its type, the study demonstrated the relation between antenatal care site and pregnancy outcome. After exclusion of women with no ANC, the total was 1977, 314 (66.8%) of safe outcomes attended both private, and primary health care centers, while the lowest, 185 (33.3%) of safe outcomes were in those who attended the primary health care center only. Table (4)

The study showed that most (422 - 86.5%) of mothers who completed immunization had safe mother and baby outcomes, while 138 (18.6%) of mothers who did not receive immunization had safe pregnancy outcomes. Table (5)

Regarding the relationship between birth spacing and safe pregnancy outcomes, of the total number of women (2080), the total of both unsafe mother and baby outcomes was (160)+(41) of unsafe mothers from abortion +(2) ectopic pregnancies (total) =203], when safe mother and unsafe baby the total was [120 + (77 safe mothers from abortion) =197]. The study showed that, spacing period (>2) years 720 (64.6%) had both mothers and babies safe, while 68 (6.1%) had unsafe mother and fetus. And regarding the spacing period (<2) years 368 (38.1%) had unsafe mothers and safe babies, while only 123 (12.7%) had safe mothers and unsafe babies. Table (6)

Regarding the risky women the study showed that the total risky mothers were (1400), while 125 (89.3%) of severe risk level had unsafe pregnancy outcomes, and 310 (43.4%) of high risk level had safe pregnancy outcomes.

The study showed that in 118 cases of abortion, there was a comparison between the type of abortion and mother health. Most 24 (92.3 %) of threatened abortion had safe mother outcomes, while the lowest, 1 (10%) of septic abortions had safe mother outcomes. But most 9 (90%) of septic abortion had unsafe mother outcomes, while lowest zero (0%) of inevitable abortions had unsafe mother outcomes. Table (7)

Among the total delivered mothers (1960), the study showed that, 969 (56.2%) of full term pregnancies had safe mother and fetus/baby, while 35 (40.7%) of preterm deliveries had safe mothers and unsafe fetuses/babies outcome. And 80 (53%) of post term delivery had safe pregnancy outcomes for both. Figure (3)

The study showed that from a total 1960 delivered women, after exclusion of abortion and ectopic pregnancy cases, 1017 (55.8%) of hospital delivery, had safe pregnancy outcomes regarding both mothers and fetus/baby, while 43 (62.3%) of those who had home delivery by a registered midwife, had safe outcomes for both, while 5 (100%) of home deliveries when not aided at all, were both mothers and babies having unsafe outcomes. Table (8)

Regarding the relationship between mode of delivery and pregnancy outcome, the total was 2040 after inclusion of twins and the study showed that, 461 (53.5%) of thosedelivered by spontaneous vaginal delivery had complications. Also 289 (61.8%) of induced vaginal delivery had complications, while in cesarean section, from 179 mergency cesarians 145 (81%) hadcomplicated delivery, but from 330 of elective C/S 30 (9.1%) were complicated. Table (9)

After exclusion of 330 elective cesareans, and 45 of emergency C/S, total women who had true labor were (1585). The study showed that, those who had normal duration of labour with safe outcomes were higher in primigravida 377 (79.9%), in comparison with multigravida 433 (73%). But in safe pregnancy outcomes with prolonged labor 91 (39.6%) were primigravida, while 40 (13.8%) were multigravida. Table (10)

The total number of women who received intra-partum fetal monitoring was 1360 after exclusion of home delivery (138), and (462) without monitoring, the study showed that, 844 (79.1%) with regular fetal heart monitoring had safe babies, while only 223 (20.9%) had complications. Furthermore, partogram was used in 273 (93.2%) with safe fetal outcomes but only 20 (6.8%) were associated with complications. Table (11) Regarding the problem of Rh incompatibility of mother and after exclusion of abortion and ectopic pregnancy cases, the total was 1960. Then the study showed that, most 1480 (89.2%) of Rh positive mothers and babies hadsafe pregnancy outcomes, while the highest 83 (51.6%) of Rh negative mothers and Rh positive babies had unsafe pregnancy outcomes. Table (12)

Regarding the effect of medical, and surgical history of mother, and family history of both parents on outcomes: In regard to medical illnesses, 51 (38.6%) of acute illnesses were associated with unsafe mother and fetus/baby outcomes, while 165 (42%) of chronic illnesses were associated with unsafe mother and fetus/babies.

Regardingsurgical history: the highest incidence 240 (59.6%) of gynecological and obstetrical operations was found in unsafe mothers and safe fetus/baby, while the highest incidence 86 (52.1%) of non gynecological operations was found in both safe outcomes for mother, and fetus/baby.

Regarding family history: the highest incidence 43 (58.9%) of family history of inherited disorders was found in safe mother and unsafe Fetus/baby outcomes, while the highest incidence 190 (78.2%) of family history of multiple pregnancies was found in both safe mother and fetus/baby, and the highest incidence 648 (59%) of family history of medical diseases was found in both safe mother and fetus/baby. Table (15)

Regarding the drug history, the study showed that, women using preconception preventive drugs with harmless effects 60 (84.5%) had both safe outcomes, while 7 (100%) of women using harmful drugs had safe mothers and unsafe babies outcomes. Regarding ante partum drugs, tonics 948 (64.9%) had both safe pregnancy outcomes; while regarding the drugs used for specific diseases for women 305 (59%) both had safe outcomes. Finally regarding intrapartum drugs which include antihypertensive drugs 43 (26.4%) had both unsafe outcomes, while using anti-convulsant drugs the study showed that 17 (56.7%) had unsafe outcomes for both, and oxytocic drugs 182 (70.3%) both showed safe outcomes. Table (16)

Furthermore the study showed the effect of risk factors on maternal and fetal/baby health. We determined the top10 factors that affect feto-maternal safety in order from highest to lowest. The study showed that 1099 (22.2%) of risk factors had family history of medical diseases, then 426 (8.6%) hadprevious C/S, then 345 (7%) had toxemia or hypertension in previous pregnancies, then anemia (<10 g/l) 338 (6.8%), then 318 (6.4%) were hypertensive women in the present pregnancy. Then 300 (6.1%) child weight (<5Ib, >9Ib), followed by risk of history of (=2) abortion or history of infertility or postpartum hemorrhage 292 (5.9%), then bleeding (>20, <20) weeks of present gestation 288 (5.8%), then 264 (5.3%) due to parity (>5), and lastly I.U.G.R. 168 (3.4%). Table (16)

Regarding the causes of perinatal mortality the study shows that of 120 perinatal mortalities, the highest 72 (60%) were due to maternal causes, while the lowest 12 (10%) were due to fetal causes (multiple pregnancy).

The study showed that total maternal deaths was 11 women. Of thesethe highest number was due to direct causes in the first (42) days which was 5 (45.4%) women. The lowest number was 1 (9.1%) due to direct and indirect causes in the period between (42) days to first year postpartum for each. Table (13)

The study showed that the total number of mothers who complained of complications was 1150. The highest incidence of maternal complications 369 (32.1%) were in the ante-partum (third trimester) period, while the lowest 3 (0.3%) were in the post-partum (after 42 days-1 year). The total number of fetuses who had complications was 446. The highest incidence of fetal complications 150 (33.6%) were in the intra-partum period, while the lowest, zero (0%) were in the post-partum (after 42 days of termination). Table (14)

The study determined the major causes of maternal mortality which were 2 (28.6%) for each of hypertensive disorders, and hemorrhagic problems of pregnancy. Maternal mortality ratio was 161 per 100,000 live births in Tikrit General Teaching Hospital. Table (17)
DISCUSSION

Making pregnancy safer for both mothers and fetuses/babies is important because for every woman who dies, 30 to 50 women suffer injury, infection, or disease. Pregnancy related complications are among the leading causes of death, and disability for women age 15-49 in developing countries. In addition, newborn health and survival are closely linked to the health of the mother before pregnancy, during pregnancy, during labor, and in the postpartum period (125).

The study showed that the predominant childbearing age group was from 16-25 years, while Mahoney R. observed that the predominant childbearing age group was from 25-34 years (126). Also our study showed that age <16, >45 years was associated with unsafe pregnancy outcomes. This agrees with Wasunna A., and Mohammed K. who observed that adolescent mothers were more likely to have increased morbidity, and adverse outcomes particularly low birth weight problems of newborns <2500 grams (127), but this rejected by Kirchengast S., and Hartman B. who observed that adolescent mothers showed no increased incidence of low birth weight problems (128).

Also Kirchengast S., and Hartman B. and Donoso E., and Villarroe L. observed that the women older than 40 years had a higher rate of cesarean section, maternal death, late fetal death, and neonatal death. This is interpreted as an increase in the mother's age is associated with an increase in mother and newborn body dimensions(128,129).

Regarding the maternal educational level, the results showed an association between uneducated mothers (illiterate) and unsafe pregnancy outcomes. This agreed with Wasunna A., and Mohammed K. in Nairobi, the study observed women who had less formal education, and who were unemployed had obstetrical risks for poor pregnancy outcomes (127).

The results showed an association between the parity group of =5 and unsafe pregnancy outcome. This was in agreement with Olatunji A.O., and Sule-odue A.O. in Nigeria, and Williams K.P. and Wilson S. that the primiparous and the grandmultiparous women had a high risk of poor pregnancy outcome particularly small for gestational age, HELLP syndrome, operative delivery, and maternal death (130,131).

Marital state showed an association between broken marital states, especially separated women and poor pregnancy outcomes.

Conditions in Iraq, and in Tikrit city particularly, mean that pregnant women suffer from stressful events, either psychological, economical, or social effects. Additionallythere are large numbers of their husbands in American Prisons that affect negatively on pregnancy outcomes. This agrees with data from Perren S., Von-Wyl A., et al, (US Conferences of Mayors), and (National Coalition for the Homelessness -NCH-). Homeless women who are pregnant usually with inadequate prenatal care, limited access to general health care, poor nutrition and inadequate housing leads to poor birth outcomes (132,133.134). The complications of homelessness include an increased incidence of low birth weight newborn, and a higher rate of infant mortality, in addition to risk of many illnesses that could negatively affect their pregnancies, or substance abuse (134).

Considering the number of fetuses, and intra-partum and post-partum complications, the results found that the mother and fetal/baby complications associated with multiple gestation, but safe pregnancy outcome associated with singleton pregnancy. This agrees with Senat M.V., et al who also determined the most common complications associated with multiple pregnancy which includes maternal anemia due to increased demand of multiple gestation, hypertension, polyhydramnios or may be due to increased renal perfusion, premature rupture of membranes, incompetent cervix, intrauterine growth restriction, and other rare complications as conjoined (Siamese) twins, and other labor complications which include preterm labor, uterine dysfunction, abnormal fetal presentation, instrumental or cesarean birth and post-partum hemorrhage (135) . But Jacquelyn Y., Martens G., et al found that the perinatal mortality was significantly lower in twins because of early fetal death, and not early neonatal mortality (136). Francois K., Johnson J.M., and Harries C. observed that the occurrence and complications of placenta previa do not differ between singleton and multiple pregnancy (137).

Regarding gender of babies the results showed no differences between both males and females with safety of pregnancy outcome. Neville F., Moore G. astated that newborn gender may provide insight into patient and family expectation and may indicate certain genetic risk factors, also fetal and neonatal complications (11).

The results found that all babies who had extreme low birth weight (<1000) grams, and very low birth weight (<1500) grams usually were unsafe babies, but in very low birth weight babies <2500 grams, the highest number had unsafe fetus/baby outcomes., This agrees with Lynch A., McDuffie R., et al (138). The results show that normal weight of babies 2500-4000 grams) had safe fetus/baby and mother, and the predominant weight (86.3%) was normal birth weight (2500-4000 grams). This agrees with Misic Z., Krezo S., et al who observed that the predominant newborn weight (93.5%) was 2500-3000 grams (139). Macrosomic babies (>4000) grams had unsafe fetus/newborn and mother outcomes. This agrees with Boulet S.L., Alexander G.R., et al (140).

Considering area of residence, whether rural or urban, there was an association between rural areas and unsafe pregnancy outcomes, and urban areas with safe pregnancy outcomes. These results interpreted as, that the rural area has limited health services. In addition there are recent circumstances of night curfews, and sometimes even during the day, as well as insufficient fuel and high prices may prevent pregnant women from reaching the central hospital in Tikrit city. This made pregnant women experience traditional birthing practices such as home delivery by unregistered midwives, or unaided delivery, due to delay in arrival to hospital. This result agreed with Kyomuhendo G.B. in Uganda, and Safdar S., Ahmed S.T. in Pakistan who observed tharpoor pregnancy outcome was more common in rural areas (141,142).

The results also showed that there is an association between the parental consanguinity and fetal/baby outcomes in that unrelated parents had safe fetal/baby outcomes, but second degree relative parents had unsafe fetus/baby outcomes according to our study results. This agrees with Sogaard M., Vedsted-Jakobsen A. who found that consanguineous couples have a higher risk of having children with congenital malformations (143). But our results disagree with Saad F.A., Jauniaux E. in Qatar, and Al-Bustan S.A., El-Zawahri M.M., Ghunaim I. et al who didn't find any relationship between consanguineous marriage and poor fetal outcome (144,145).

Our study shows a positive relationship between prolonged spacing of >2 years as average spacing between pregnancies and good fetal/baby and maternal health, but too close pregnancies are associated with poor pregnancy outcomes. These findings agreed with the result found by (Anonymous) that the couples who space their birth (3-5) years apart increase their children's chance of survival, and mothers are more likely to survive (146).

Also our study agreed with King J.C. who found that women with early or closely spaced pregnancies have increased risk of fetal-maternal morbidity and mortality due to maternal nutrient depletion (125). Other studies done by Rachel A., and Royce, and Agudelo A.C., et al showed that close pregnancies, less than 18 months, had poor pregnancy outcomes. This result was due to maternal nutritional depletion, while the same study showed no statistically significant differences in risk between women with pregnancy interval 18-24 months, and those with intervals of 24-59 months. Regarding intervals longer than 59 months, it is observed that there are more maternal and fetal/baby problems, due tothat the woman's physiologic reproductive capacity decline and thus becoming similar to those of primigravida women. (19,147)

Considering abortion, the results showed that the abortion rate was 5.7% from the total sample (2080). Safe mother outcomes in cases of abortion were more than unsafe mothers. These results were due to increased maternal health education about the consequent complications of unsafe abortion, and availability of medical services such as medical staff, specialist doctors in obstetrics, trained sub staff, and ultrasonography. Finer L.B., Henshaw S.K. found abortion rate in (2000), in United State was (5%) (148). Our study did not determine the causes of abortion accurately, even maternal or fetal factors, because that needs some investigations which are not available in our hospital or even in Salah Al- Deen governorate, or it may be expensive and need a long time, but the results determined the risk factors of unsafe pregnancy outcome and abortion is part of it. There are different studies about risk factors of abortion, Talukder S.I., and Haque A. and Qublan H.S., Jumaian N., et al observed variation in the frequency of abortion found to be highest in the hot seasons, rural areas, old age women, and high parity (149,150).
Diejomaoh M.F., Al-Azemi M., et al in Kuwait determined the main etiological factors of recurrent pregnancy loss were uterine anomaly, chromosome anomaly, polycystic ovarian syndrome, infections, and other miscellaneous factors. Positive phospholipids antibodies are a most frequently associated cause of recurrent pregnancy loss in Kuwait (151).

Considering antenatal care 65.5% of the sample had good antenatal care, and 29.5% had poor antenatal care, and 5% had no care at all. There was an association between good antenatal care and safe mother and fetus/baby outcomes because frequent visits and checking can determine the risky groups, and follow up during pregnancy can determine the appropriate mode of delivery; while there are increased complications in women who had poor antenatal care. This is documented by Chang J., Elam-Evans L.D., et al in the United States, and Olatunji A.O., and Sule-Odu A.O. in Nigeria who observed that unbooked patients were associated with poor pregnancy outcomes and even pregnancy related death (152,130).

Regarding the antenatal care site, whether private clinics or primary health care centers or both, our study showed that the women who attended both private doctor's clinics and primary health care centers were associated with better pregnancy outcomes. This disagrees with Harvey S., Rach D., et al in Canada who observed the significantly higher satisfaction of the women with care provided by the midwives together with better clinical outcomes, than doctors' care (153).
Immunization with tetanus toxoid for pregnant women: There is a known schedule used in Iraq which includes four doses. The first dose is given in the first 6 weeks of pregnancy which gives no protection, the second dose is given 4-6 weeks later which gives protection for 3 years. The third dose is given 6 months later which gives protection for the next 5 years, and the fourth dose is given one year later which gives protection through the reproductive life. The result showed that, there were positive associations between those women who completed their tetanus toxoid immunization and good pregnancy outcomes. This result, is documented by Nasheit N.A. in Iraq, - that the tetanus toxoid played a role in decreasing perinatal mortality in Iraq (154).

Considering risk factors of mothers which determined the level of risk according to special risk scoring system, the previous results demonstrated in the discussion covered most of the risk factors and their effects, inregards to the maternal weight affecting pregnancy outcomes, most of the women with extreme weight had complications according to our results, that agree with Neggers Y., and Goldenberg R.L. and Edmonds D.K. (155, 28). Regarding maternal height, most of the women shorter than 150 cm were associated with mother and fetal/baby complications, but it may be due to the contribution of other risk factors. Edmonds D.K. observed that except in extreme cases (such as kyphoscoliosis or rickets) short stature has only a weak association with pelvic contraction, and is not usually an indication for extra care (28).

Regarding the duration of pregnancy, the baby delivered either preterm (before 37 completed weeks of gestation), or term at period 37-42 completed weeks of gestation, or post term (after 42) completed weeks of gestation) in our study, showed that there are variations in the mother and fetus/baby complications that depend on the cause of preterm, and post term delivery, type of management of labor, and neonatal care facilities which are insufficient in Tikrit Teaching General Hospital. All of these factors decided the fate of pregnancy. The study showed that full term, and post term delivery associated with better outcome than preterm delivery.

Regarding preterm delivery, our results agree with Garland S.M., Ni-Chuileannain F. et al who observed that premature or preterm delivery increased fetal susceptibility to cerebral palsy and neonatal sepsis that increases mortality, particularly extreme prematurity (156).

Ananth C.V., Smulian J.C., and Vintzileos A.M. in United States showed that the effect of placenta previa and neonatal mortality rate is according to duration of pregnancy. The risk of death from placenta previa was lower among preterm babies and higher in women without placenta previa, while mortality rates for term births were higher among babies born to women with placenta previa than among babies born to women without placenta previa (157).

Regarding the post term delivery Treger M., Hallak M., et al had a study that showed that the main problems associated with post term pregnancy are stage I, II, meconium stained amniotic fluid, macrosomia, and cesarean section were significantly higher with increasing gestational age and to decrease these problem, labor induction should be indicated at appropriate gestational age (158). This was opposite to our study results.

Regarding the duration of labor, maximum duration in multipara is 14 hours, and in primipara is 20 hours from commencement of true labor (10). The results showed that prolonged labor is associated with increased labor omplications for both primiparous and multiparous women and their babies. This result agrees with Maghoma J., and Buchmann E.J. (159).

The results showed that the hospital delivery rate is more than the home delivery rate. This may be due to the type of study which was a hospital based study, and women who have home delivery usually to not attend the hospital, unlesssevere complicationsoccur. In addition, recent conditions that include difficulty in transport from home to hospital due to fuel deficiency and night curfews, that make women prefer to attend the nearest PHCC or private doctor's clinic, and home delivery than coming to hospital. This agrees with Kaufman J., and Jing F. in China who observed that hospital delivery had more safe pregnancy outcomes (160).But Janssen P.A., et al in British Columbia disagreed with our result when they observed that planned home birth was not associated with an increase in mothers' and fetuses/babies' complications. They interpreted their results as due to labor managed by well trained midwives (161).Conversely our results showed that where labor was managed by registered midwives, it ewith better outcomes than non registered midwives. This disagrees with the result of Goldman N., and Glei D.A. in Guatemala who observed similar results between trained and untrained midwives (162).
Considering mode of delivery and feto-maternal complications at intra-partum and post-partum periods, the results showed that labor induction was associated with mothers, and fetuses/babies complications more than complications from spontaneous vaginal delivery. This disagrees with Shanchez-Ramos L., and Hsieh E. who observed that labor induction provided the surveillance for maternal and fetal safety (163).

Regarding instrument delivery, the results showed that forceps delivery had safe outcomes higher than unsafe outcomes, but vacuum delivery was not in use due to instrumental defect. Ben-Aissia N., Gara M.., et al observed that the major indication of forceps use was fetal suffering, and the maternal and fetal prognosis depended on accurate indication of the use of forceps (164). Shihadeh A. and Al-Najdawi W. observed that maternal birth canal and genital tract lacerations were significantly more common in forceps delivery and there was significantly increased morbidity in infants delivered by vacuum extraction (caput, jaundice, cephal hematoma), and serious neonatal morbidity was rare for both groups (165). Considering cesarean section, the results showed that emergency cesarean section was associated with higher rate of mothers and fetuses/babies complications than elective. This result agreed with Bergholt T., Stenderup J.K., et al in Denmark (166).

The objective of intra-partum fetal heart monitoring is to prevent fetal asphyxia, and fetal death during labor. The results showed that regular fetal heart monitoring ended with good fetal/baby outcome because the clinician can manage labor according to fetal monitoring results This agreed with Freeman R.K., Williams K.P., and Galerneau F., and Carbonne B., Gougeal V., and Fekih K.M. (167,168,169).

The use of partogram was limited in Tikrit Teaching General Hospital because of insufficient or unavailable papers of partogram that need economicsolutions. Our results showed that the use of partogram in labor ended with safe mothers and fetuses/babies, this agreed with Pattinson R.C., Howarth G.R., et al who found that the partogram played an important role in labor outcomes (170).

Regarding the Rh of mothers and babies, a large number (84.7%) of mothers were Rh positive. These results compared with Weiner C.P. who found that approximately 85% of white Americans, 92%-93% of African Americans, and 99% of the Asian population are Rh positive (171). The mother with Rh negative, and baby Rh positive had unsafe fetal/baby outcomes, either due to the problem of incompatibility or other problems, Rh incompatibility happened when the mother was previously sensitized, but iso-immunization can be prevented if the mother receives Anti-D in the first (72) hours post termination of each pregnancy according to our results. (American College of Obstetricians and Gynecology) observed the highest risk of Rh incompatibility if mothers were previously sensitized (172).

The results showed a high rate of maternal complications in the antenatal period, particularly at third trimester. This agrees with Chakraorty N., Islam M.A., et al in Bangladesh who observed a high rate of complications in the antenatal period (173).This large number of complications interpreted that, the women recall the problems because of the seriousness of these problems, or the same women had multiple problems in the antenatal period. These problems include ante-partum hemorrhage, premature rupture of membrane, or leakingfluid, threatened preterm labor and its causes, gestational hypertension and other problems.

The results showed the highest rate of fetus/baby complications occurred in the post-partum period. This disagrees with Buchmann E.J., and Pattenson R.S. who observed the highest frequency of fetal complications in the intra-partum period, especially birth asphyxia (174).
Regarding maternal use of drugs taken in preconception, ante-partum, and intra-partum periods, and fetomaternal.

Outcomes: The results showed that the preconceptional drugs with harmless effects were associated with safe pregnancy outcomes, such as using of folic acid in the prevention of birth defects and neural tube defects. This agrees with French M.R., Barr S.I., and Levy Milne R. and Barash J.H., and Weinstein L.C. (175,176).

Regarding ante-partum drugs, the results showed that tonics used during pregnancy were associated with safe mother and fetus/baby outcomes. \-his result agrees with Correa A., Botto L., et al (177).

Other drugs used in the ante-partum period to treat specific diseases such as anti- hypertensive drugs, depends on the type of drugs used and theirside effects. This agreed with Duley L., and Henderson-Smart D.J. (178).

Other drugs used in the ante-partum period were corticosteroids to decrease respiratory distress syndrome. It is given in three doses as 12 mg for three consecutive days to induce fetal lung maturation in threatened preterm labor to decrease perinatal morbidity and mortality. The results showed the positive role of corticosteroid, but Cran J., Armson A., et al observed that a single course of corticosteroids reduces perinatal mortality, respiratory distress syndrome, and intra-ventricular hemorrhage, while repeated courses of corticosteroids decrease respiratory distress syndrome, but increase rates of neonatal and maternal
infection, fetal, neonatal, and maternal adrenal suppression, decreased fetal or neonatal somatic and brain growth and increased perinatal mortality (179).

Regarding drugs used in the intra-partum period, the results showed that the hypertensive women who needed intra-partum antihypertensive drugs had high blood pressure during labor, and this hypertension did not respond to usual ante-partum antihypertensive drugs, or women had no antenatal care of diagnosed hypertension; therefore doctors try other drugs to save mothers and fetuses/babies life if possible, and according to our results both maternal and fetal/baby outcomes are affected negatively in this group of pregnant women.

Also the results showed that the women exposed to oxytocic drugs in the intra-partum period are associated with safe pregnancy outcomes. This result agrees with Pattinson R.C., Howarth G.R., et al (170).

Regardinganticonvulsant drugs: (Valium, Phenobarbital, and sometimes general anesthesia) used during labor, and they were given when convulsion occurs due to hypertensive disorders that are associated with unsafe mothers and fetuses/ babies. But Alberta by Foong S.C., and Pollard J.K. observed that use of seizure prophylaxis for all women with gestational hypertension from time of diagnosis through to (24) hours postpartum, may have been able to prevent as many as 53% of eclamptic episodes (180).

Many factors such as maternal history of medical diseases (acute and chronic infectious diseases, hypertension, diabetes mellitus, anemia, cardiovascular diseases, renal diseases, epilepsy, psychological illnesses, and others), maternal gynecological and obstetrical surgery (ovarian, tubal surgery, uterine fibroid, cesarean section, cervical, and others), and family history of inherited disorders (bleeding disorders, chromosomal abnormality, congenital anomalies, and others) all affect negatively on pregnancy outcomes. Most common medical diseases of mothers that affect fate of pregnancy wereanemia, particularly severe anemia were associated with increased mother and newborn morbidity. This agrees with Malhorta M., Sharma J.B., et al in a tropical African setting (181). The other common disease was eclampsia which was a major cause of maternal and fetus/baby morbidity and mortality. This agrees with Beye M.D., Diaouf E., et al (182). Other disease was diabetes mellitus and epilepsy, which are closely linked to an increased risk of fetal malformation, and this agree with Steel et al (183).
The high rate of perinatal mortality in our study is mainly related to maternal causes. This agreed with Aisien A.O., Lawson J.O., et al in Nigeria (184). The perinatal mortality rate related to fetal causes, agrees with Kinzler W.L., Ananth C.V., et al who found that small size ofgestational age, if exposed to labor stress, increases the risk of early neonatal death (185). According to our results obstetrical complications had the least effect on perinatal mortality. This was interpreted that most fetuses at risk of labor complications were planned for appropriate management or due to contribution of maternal and fetal causes. This agrees with Bari W., et al) who observed that perinatal death associated with obstetrical complications as assisted delivery (186),but Sheiner E. et al) who disagree with our study, observed that obstetrical problems had independent associations with perinatal mortality (187).

The study results showed the high rate of maternal mortality due to direct causes during pregnancy, and in the (first 42 days) post partum. The common causes were hypertensive disorders, postpartum hemorrhage, and thromboembolic problems. These results are explained as, early death at first 42 days may be at labor or after a short time when the mother is still in hospital, and is recorded as pregnancy related death. But the lower rate of maternal mortality was in the period (after 42days - 1year) of pregnancy termination. Berg C.J., et al in the United States showed that the pregnancy related mortality ratio increased, probably because of improved identification of pregnancy related death, and common causes were embolism, hemorrhage, and other medical conditions (188).

Meta-analysis provides an opportunity to examine consistency of the results across studies, in relation to quality of studies, and we can provide a plot of results with only the best studies included and then with successive inclusion of varying levels of quality, of the studies(115).
Our study showed that the common maternal mortality causes were hypertensive disorders, and hemorrhagic complications of pregnancy, in addition to embolism, sepsis, and cerebrovascular accidents which were less frequent than the first two causes.

Maternal mortality ratio and causes of our study compared with other studies: Gaym A), Sloan N.L., Langer A., Hernandez B., Romero M., and Winikoff B., and Berg C., Chang J., Callaghan W.M., and Whitehead S.J. agreed with our results that hemorrhage problems of pregnancy, hypertensive disorders of pregnancy, and sepsis were mutual leading causes of maternal mortality(188,189,190) . But Berg C.J., Chang J., Callaghan W.M., and Whitehead S.J. agreed with our results that embolism and cerebrovascular accidents form the leading causes of maternal mortality (188).
CONCLUSIONS AND RECOMMENDATIONS

6.1. Conclusions:
6.1.1. Safe fetus/baby and mother outcomes in relation to maternal factors were found in married women, parity group of (1-4), pregnancy spacing >2 years, good antenatal care, mothers who attended both private clinics and primary health care centers, low risk level, women received tonics during pregnancy, and those who received tetanus immunization.

6.1.2. During labor, complications decreased with hospital site of delivery, normal duration of labor for both primiparous and multiparous women, and elective cesarean section and forceps delivery were associated with no complications.

6.1.3. Safe fetus/baby and mother, in relation to fetal factors associated with full term babies with normal birth weight, Rh +ve for both mother and baby, regular fetal heart monitoring during labor, and single fetuses pregnancy.

6.1.4. Male and female gender of baby had nearly equal effect on safety of mothers and fetuses/babies.

6.1.5. Maternal and fetal/baby complications mostly associated with maternal age group <16, >45 years, illiterate mothers, rural living mothers, and these complications mostly happened in ante partum period during recent pregnancy.

6.1.6. Perinatal mortality is most common due to maternal causes.

6.1.7. Maternal mortality is most common in the first (42) postpartum days due to direct causes.

6.1.8. Most common risk factors were family history of medical diseases, previous cesarean section, low birth weight babies, ante partum hemorrhage, and toxemia in that order.

6.1.9. Maternal mortality happened due to hypertensive disorders, and hemorrhagic problems of pregnancy.

6.2. Recommendations:
6.2.1. Improve maternal health by:
a. Clean and safe delivery by skilled attendant at birth of all mothers.
b. Community awareness of maternal health needs.
c. Improvement of health status of women.
d. Improve health professional performance.
e. Integrate referral hospital services into the existing primary health care services.
f. Develop appropriate strategic polices for referral hospital including antenatal, postnatal, family planning, and emergency obstetric care.
g. Reporting system for domestic and other violence against women.
h. Community awareness of family planning and advantage of child spacing.
i. Laws and legislation for midwifery.
j. Continuing pre services and in services health education.
k. Strengthening monitoring system for maternal mortality.

6.2.2. Improve neonatal health by:
a. Quality care of the newborn babies by introduction of modern/new technologies and, skilled staff.
b. Action oriented newborn death surveillance system.
c. Introducing early detection and management of hereditary diseases.
d. Introduce genetic counseling services.


Table (1):  Effect of maternal factors on the mother, and on the fetus/newborn outcome.
Factors Outcome
Safe Unsafe Total
No. % No. % No. %
*Maternal age            
<16 years 2 4.8 40 95.2 42 0.5
16-25year 518 56.4 400 43.6 918 11
26-35years 446 51.5 420 48.5 866 10.4
36-45years 90 38.3 145 61.7 235 2.8
>45years 4 21.1 15 78.9 19 0.2
*Educational level            
Literate 728 76 230 24 958 11.5
Illiterate 332 29.6 790 70.4 1122 13.5
*Parity            
Zero 439 49.4 449 50.6 888 10.7
1-4 523 56.4 405 43.6 928 11.2
≥5 98 37.1 166 62.9 264 3.2
*Marital state            
Married 1054 54.1 896 45.9 1950 23.4
Divorced 1 7.7 12 92.3 13 0.2
Widowed 2 5.3 36 94.7 38 0.5
Separated 3 3.8 76 96.2 79 0.9
Subjects 4240 3.8 76 96.2 79 0.9
P value less than 0.001D.F=14

<< Back to text

Table (2): Effect of fetal factors on the mother, and on the fetus/newborn outcome.
Fetal factors

Outcome

Safe Unsafe Total
No. % No. % No. %
*No. of fetuses            
Single 1068 54.5 892 45.5 1960 32

Multiple

13 16.2 67 83.8 80 1.3
*Gender            
Male 540 53 478 47 1018 16.6
Female 541 53 481 47 1022 16.7
*Weight            
Extreme LBW<1000gm 0 0 3 100 3 0.1
Very LBW<1500gm 0 0 74 100 74 1.2
LBW<2500gm 0 0 134 100 134 2.2
Normal (2500-4000)gm 1080 61.3 681 38.7 1761 28.8
Macrosomia >4000gm 1 1.5 67 98.5 68 1.1
Subjects 3243 53 2877 47 6120 100

P value less than 0.001D.f= 8

<< Back to text

Figure (1): Relation of Residency with mother, and fetus/newborn outcome.

<< Back to text

Figure (2): Effect of parental consanguinity on fetus/newborn outcome.

<< Back to text

Table (3):  Effect of antenatal care (ANC) on the mother, and on the fetus/newborn outcome.

ANC

Outcome

Safe

Unsafe

Total

No.            %

No.           %

No.             %

Good (>5 visits)

939 68.9 424 31.1 1363 65.5

Poor (<5 visits)

108 17.6 506 82.4 614 29.5

None

13 12.6 90 87.4 103 5

Subjects

1060 51 1020 49 2080 100
Chi square=509.6 Degree of freedom=2

<< Back to text

Table (4):  Effect of ANC site on the mother and on the fetus/newborn outcome. 
Site of ANC

Outcome

Safe

Unsafe

Total

No.

%

No.

%

No.

%

Private

548 57.6 403 42.4 951 48.1

PHCC

185 33.3 371 66.7 556 28.1

Both

314 66.8 156 33.2 470 23.8

Subjects

1047 53 930 47 1977 100
Chi square=89.8 Degree of freedom=2

<< Back to text

Figure (3): Risky women levels and outcome of the mother, and the fetus/newborn

<< Back to text

Table (5): Effect of maternal immunization with tetanus toxoid on the mother and the fetus/newborn outcome.

Immunization

Outcome

Safe Unsafe Total
No. % No. % No. %
*Received            
-Complete 422 86.5 66 13.5 488 23.5
-Partial 500 58.7 352 41.3 852 41
*Not received 138 18.6 602 81.4 740 35.5
Subjects 1060 51 1020 49 2080 100
Chi square= 576 Degree of freedom= 2

<< Back to text

Table (6): Effect of birth spacing (average spacing period among all pregnancies) on the mother and the fetal/newborn outcome.
Complications
Period of spacing  
<2years

 >2years

 Subjects

No. % No. % No. %
Both  safe 340 35.2 720 64.6 1060 51
Both unsafe
135 14 68 6.1 230 9.7
SmUb
123 12.7 74 6.7 197 9.5
UmSb
368 38.1 252 22.6 620 29.8
Total
966 46.4 1114 53.6 2080 100
Chi square= 182.5 Degree of freedom= 3

 
Figure (4): Duration of pregnancy and outcome of the mother, and the fetus/newborn.

SmUb=Safe mother and unsafe baby. UmSb=Unsafe mother and safe baby.

<< Back to text

 

Table (7): Effect of abortion types (11, 31) on maternal safety.

Types

Outcome
Safe Unsafe Total
No. % No. % No. %
*Spontaneous            

-Threatened

24

92.3

2

7.7

26

22

-Inevitable

6

100

0

0

6

5.1

-Incomplete

20

80

5

20

25

21.2

-Complete

12

66.7

6

33.3

18

15.3

-Missed

2

25

6

75

8

6.8

-Habitual

4

28.6

10

71.4

14

11.8

-Septic

1

10

9

90

10

8.5

*Therapeutic

8

72.7

3

27.3

11

9.3

Subjects

77

65.3

41

34.7

118

100

Chi square=41.4 Degree of freedom=7

<< Back to text

Table (8): Effect of delivery site on the mother and on the fetus/newborn outcome.

Site of delivery

Outcome

Both safe

Both unsafe

UmSb

SmUb

Subjects

No.

%

No.

%

No.

%

No.

%

No.

%

*Hospital

1017

55.8

125

6.9

586

32.2

94

5.1

1822

93

**HomeBy:-                    
Registered midwife

43

62.3

0

0

0

0

26

37.7

69

3.5

Non registered midwife

0

0

30

46.9

34

53.1

0

0

64

3.3

Not aided at all

0

0

5

100

0

0

0

0

5

0.2

Total

1060

54.1

160

8.2

620

31.6

120

6.1

1960

100

Chi square= 455.5 Degree of freedom= 9

Table (9):  Relation of mode of delivery and (intra-partum -postpartum) on the mother and the fetus/newborn complications.

Mode of delivery

Complications

+ve -ve

Total

No.

%

No.

%

No.

%

*Spontaneous vaginal delivery

461

53.5

400

46.5

861

42.2

*Induced vaginal delivery

289

61.8

179

38.2

468

22.9

*C/S            
-Emergency

145

81

34

19

179

8.8

-Elective

30

9.1

300

90.9

330

16.2

*Instrumental            
-Forceps

34

16.8

168

83.2

202

9.9

-Vacuum

0

0

0

0

0

0

Subjects

959

47

1081

53

2040

100

Chi square= 403.2 <'>Degree of freedom= 5

<< Back to text

Table (10): Effect of labor duration (11) on the mother and the fetus/newborn outcome.
Outcome Primigravida Multigravida Subjects

<20 hours

<20

hours

<14 hours

>14 hours

 

No.

%

No.

%

No.

%

No.

%

No.

%

Safe

377

79.9

91

39.6

433

73

40

13.8

941

59.4

Unsafe

95

20.1

139

60.4

160

27

250

86.2

644

40.6

Total

472

29.8

230

14.5

593

37.4

290

18.3

1585

100

Chi square= 415.4 <'>Degree of freedom= 3
Table (11): Type of fetal monitoring during labor and  perinatal complications.
Fetal monitoring Perinatal complications

+ve

-ve

Total

N0.

%

No.

%

No.

%

*Regular fetal heart monitoring

223

20.9

844

79.1

1067

78.5

*Partogram

20

6.8

273

93.2

293

21.5

*Fetal PH estimation

0

0

0

0

0

0

Subjects

243

17.9

1117

82.1

1360

100

Chi square= 31.1 <'>Degree of freedom= 2

<< Back to text

Table (12):  Effect of maternal Rh on the fetus/newborn outcome.

Rh of mother

Outcome

Safe Unsafe Total
No. % No. % No. %
Rh +ve

1480

89.2

180

10.8

1660

84.7

Rh-ve mother (Rh+ve baby)

78

48.4

83

51.6

161

8.2

Rh-ve mother (Rh-ve baby)

122

87.8

17

12.2

139

7.1

Subjects

1680

85.7

280

14.3

1960

100

Chi square= 199.2 Degree of freedom=2
Table (13): Maternal death and its causes.
Causes Maternal death Subjects

No.

%

No.

%

* First 42 days        
-Direct

5

45.4

5

45.4

-Indirect

2

18.2

2

18.2

*After 42days-1 year        
-Direct

1

9.1

1

9.1

-Indirect

1

9.1

1

9.1

*Coincidental

2

18.2

2

18.2

Total

11

100

11

100

<< Back to text

Table (14): complications outcome

Time Complications

Mother

Fetal/newborn

Subjects

No.

%

No.

%

No.

%

*Ante partum            
 -1st trimester

280

24.3

93

20.9

373

23.4

 -2nd trimester

231

20.1

15

3.4

246

15.4

 -3rd  trimester       

369

32.1

25

4.9

391

24.5

*Intrapartum

129

11.2

150

33.6

279

17.5

*Postpartum

           

-Early:

           
-1st 24 hour

56

4.9

142

31.8

198

12.4

-After 24 hour

34

2.9

8

1.8

42

2.6

-Late:

           
-Before end of  42 day 

48

4.2

16

3.6

64

4

         -After 42 days-1st year 

30

0.3

0

0

3

0.2

Total

1150

72.1

446

27.9

1596

100

Chi square= 440.9 <'>Degree of freedom= 7

<< Back to text

Table (15):  Effect of maternal drug history on the mother and the fetus/newborn outcome.

Drug history

Outcome

Both safe

Both unsafe

SmUb

UmSb

Total

No.

%

No.

%

No.

%

No.

%

No.

%

*Preconcep- tional preventive drugs                    
-Harmful 0 0 0 0 7 100 0 0 7 0.4
-Harmless 60 84.5 11 15.5 0 0 0 0 71 2.9
*Antepartum                    
-Tonics 948 64.9 0 0 20 1.4 492 33.7 1460 60.5
-Drug for specific disease 305 59 36 6.9 64 12.4 112 21.7 517 21.4
*Intraparum                    
-Antihype- tensive 2 2.9 43 61.4 19 27.1 6 8.6 70 2.9
-Oxytocic drugs 182 70.3 56 21.6 18 6.9 3 1.2 259 10.7
-Anticon- vulscent 1 3.3 17 56.7 0 0 12 40 30 1.2
Subjects 1498 62 163 6.8 128 5.3 625 25.9 2414 100
Chi square= 787.1 Degree of freedom=21

 

 

 

 

 

 

 

 

 

 

Table (15) cont.

Both safe

Both unsafe

SmUb

UmSb

Total

No.

%

No.

%

No.

%

No.

%

No.

%

*Medical diseases

                   

-Acute illnesses

51

38.6

35

26.5

18

13.7

28

21.2

132

5.3

-Chronic illnesses

80

20.4

165

42

43

10.9

105

26.7

393

15.7

*Surgical  operations

                   

-Gynecological & obstetrical

115

28.5

46

11.4

2

0.5

240

59.6

403

16

-Non gynec-ological

86

52.1

8

4.8

11

6.7

60

36.4

165

6.6

* Family history

                   

-Inherited disorders

14

19.2

9

12.3

43

58.9

7

9.6

73

2.9

-Multiple pregnancy

190

78.2

18

7.4

4

1.6

31

12.8

243

9.7

-Medical diseases

648

59

65

5.9

36

3.3

350

31.8

1099

43.8

Subjects

1184

47.2

346

13.8

127

6.3

821

32.7

2508

100

Chi square= 907.3 Degree of freedom=18

Back to text

Table (16): Comparison among risk factors of pregnant women and outcome of mother and fetus/newborn.

Risk Factors

Outcome

Safe

Unsafe

Total

No.

%

No.

%

No.

%

*Age<16, >45years

6

9.8

55

90.2

61

1.2

*Parity >5

98

37.1

166

62.9

264

5.3

*>=2 abortion or history of infertility or PPH

112

38.4

180

61.6

292

5.9

*Toxemia or hypertension

154

44.6

191

55.4

345

7

*Previous      C\S

40

9.4

386

90.6

426

8.6

*Abnormal or difficult labor

7

17.9

32

82.1

39

0.8

*Child <5 lb, >9 lb

8

2.7

292

97.3

300

6.1

*Gestational diabetes

5

20

20

80

25

0.5

*Chronic renal diseases

1

8.3

11

91.7

12

0.2

*Cardiac diseases

0

0

18

100

18

0.4

*Previous gynecological surgery

26

37.7

43

62.3

69

1.4

*Other significant medical diseases

10

12.2

72

87.8

82

1.7

**For present pregnancy

           

**Bleeding >20  wk, <20wk of gestation

91

31.6

197

68.4

288

5.8

Anemia <10 g/l

199

58.9

139

41.1

338

6.8

**Postmaturity

80

53

71

47

151

3.1

**Hypertension

176

55.3

142

44.7

318

6.4

**PROM

28

37.8

46

62.2

74

1.5

**I.U.G.R.

0

0

168

100

168

3.4

**Polyhydramnios

22

26.5

61

73.5

83

1.8

**Multiple pregnancy

10

25

30

75

40

0.8

**Breech or malpresentation

25

23.8

80

76.2

105

2.1

**Isoimmunization

78

48.4

83

51.6

161

3.2

***Others

           

***Weight <45kg,>90kg

12

22.2

42

77.8

54

1.15

***Height<150 cm

18

34.6

34

65.4

52

1.05

***Family history of Inherited disorders

14

18.2

63

81.8

77

1.6

***Family history of medical diseases

648

59

451

41

1099

22.2

Subjects

1868

37.4

3073

62.6

4941

100

<< Back to text

Table (17): The characteristics of included studies.

Study

Method

Population

Outcome

1. Asheber Gaym, 2000

A retrospective study of hospital maternal death at Jima hospital, Southwestern Ethiopia for 9 years (September 1990-May 1999)

Both direct and indirect maternal death during pregnancy, or delivery or within 42 days of pregnancy termination according to WHO definition.

Maternal mortality ratio=1965 per 100 000 live births.

Common causes of maternal deaths:

1. Obstructed labor=45.5%.

2. Sepsis=40%.

3. Ruptured uterus=33.2%.

4. Haemorrhagic complications of pregnancy=11.1%.

5. Hypertensive disorders =3.8%.

2. Sloan N.L., Langer A., Hernandez B., Romero M., and

Winikoff B., 2001.

Retrospective study on maternal deaths on autopsy in Mexico, at 1995.

Autopsy of died mothers due to direct and indirect maternal death according to WHO definition.

Maternal mortality ratio=53 per 100 000 live births.

1. Hypertensive disorders= 64.6%.

2. Hemorrhagic complications of pregnancy=51.9%.

3. Sepsis= 18.5%.

4. Obstructed labor=9.7%.

5. Abortion= 5.5%.

3. Berg C.J., Chang J., Callaghan W.M., Whitehead S.J., 2001.

A retrospective study in United State, 1991-1997.

Both direct and indirect maternal deaths according to WHO definition.

Maternal mortality ratio=12 per 100 000 live birth.

1. Thromboembolic complications=19%.

2. Hemorrhagic complications of pregnancy=18%.

3. Hypertensive disorders of pregnancy=16%.

4. Sepsis= 13%.

5. Cardiomyopathy= 7%..

4. Our study.

A retro prospective study in Tikrit General Teaching Hospital, at 2005-2006 (November 2005-April 2006).

Both direct and indirect maternal deaths according to WHO definition.

Maternal mortality ratio=161 per 100 000 live birth.

1. Hypertensive disorder=28.6%.

2. Haemorrhagic disorder of pregnancy=28.6%.

3. Embolism=14.3%.

4. Sepsis=14.3%.

5. Cerebrovascular accident=14.3%.

REFERENCES

  1. 1. World Health Organization. Reproductive health research. WHO,Geneva, 2002:25-26.

    2. World Health Organization. Safe Motherhood Report. WHO, Geneva, 2006.

    3. MICS Survey 2000, CSO/Iraq, MOH Statistics Section, NRI in MOH of Iraq, UNICEF, ICMMS/ Iraq, 1999.

    4. Salah Al-Deen health office. Statistical records, 2005.

    5. Tikrit General Teaching Hospital Statistical Records, 2005.

    6. Tinker, Anue, and Koblinsky M. Making motherhood safer world bank discussion paper 202. Washington,1. World Health Organization. Reproductive health research. WHO, Geneva, 2002:25-26.

    2. World Health Organization. Safe Motherhood Report. WHO, Geneva, 2006.

    3. MICS Survey 2000, CSO/Iraq, MOH Statistics Section, NRI in MOH of Iraq, UNICEF, ICMMS/ Iraq, 1999.

    4. Salah Al-Deen health office. Statistical records, 2005.

    5. Tikrit General Teaching Hospital Statistical Records, 2005.

    6. Tinker, Anue, and Koblinsky M. Making motherhood safer world bank discussion paper 202. Washington, World Bank; 1993.

    7. WHO Regional office for South East Asia. Safe motherhood Report, WHO, 2006.

    8. Brannigan R.E., and Lipshultz L.I. Sperm transport and capacitnation. In: Sciarra J.J., and Watkins T.J. Gynecology and obstetrics. Vol.5. Philadelphia, Lippincott Williams and Wilkins; 2000: 3.

    9. Cunningham F.G., Grant N.F., Leveno K.J., et al. Williams obstetrics. 21st edition. New York, MC Graw-Hill; 2001:221-230.

    10. Sekhri R., Kate C., Stephen N. Prescription for the Boards USMLE step2. First edition. United State of America, Little brown and company; 1996: 203-235.

    11. Neville F., and Moore G. Essential of obstetrics and gynecology. 2nd edition. United State of America., Saunders Company; 1992: 24, 120-194,294,628.

    12. Chamberlain G.V.P. Obstetrics. 16th edition. London, British Library; 1995: 102-105, 298-300.

    13. Salder T.W. Langman`s medical embryology. 8th edition. Philadelphia, Lippincott Williams and Wilkins; 2000: 173.

    14. World Health Organization. Safe motherhood Report. WHO, Geneva, In 7th April 1998.

    15. Arias F. Practical guide to high risk pregnancy and delivery. United State of America, Mosby-year book; 1993:4,55-81.

    16. Ralph C. Current obstetric and gynecologic diagnosis and treatment. 4th edition. California, Lange medical publication; 1982: 616.

    17. Ralph C. Handbook of obstetrics and gynecology. 7th edition. California, Lange medical publication; 1980:103-128.

    18. Maternal, Child, and Reproductive Health Strategy in Iraq (2005-2008). Iraq, Ministry of Health, 2004.

    19. Rachel A., and Royce. Birth spacing the long and short of it. Journal of the American Medical Association. 2006; 295(15): 1837.

    20. Eliakin R., Abulafia O., and Sherer D.M. Hyperemesis Gravidarum. A current Review. American Journal of Perinatalogy. 2000; 17(4):207-210.
    21. Power M.L., Holzman G.B., and Schulkin J. A survey on the management of nausea and vomiting in pregnancy by obstetrician and gynecologists. Primary care update for Obstetric/Gynecology. 2001; 8(2):69-72.

    22. American College of Obstetricians and Gynecologists (ACOG). Gestational diabetes (ACOG Practice Bulletin No.30). Washington, DC: Author.2001a.

    23. Reece E.A. The history of diabetes mellitus. In: Reece E.A., and Cousten D.P. Diabetes mellitus in pregnancy. New York, Churchill Livingstone; 1995: 7.

    24. Queenan J.T. Management of high risk pregnancy. 4th edition. United State of America, Black well science; 1999:368.

    25. Israel High-Tech and Investment. Report ,May 2005.

    26. Mushburn J. Ectopic Pregnancy. Triage do`s and don`ts. Journal of Nurse Midwifery. 1999; 44(6):550.

    27. Stovall T.G., Ling F.W., Gray L.A., Carson S.A., and Buster J.E. Methotrexate treatment of unruptured ectopic pregnancy: A report of 100 cases. Obstetric and Gynecology. 1991; 77: 749.

    28. Edmonds D.K. Dewhurst`s Textbook of Obstetrics and Gynecology for postgraduates. 6th edition. London, Blackwell Science; 1999: 96-97.

    29. Gracia C.R., and Barnhart K.T. Diagnosing ectopic pregnancy. Obstetrics and gynecology. 2001; 97(3):465.

    30. Lipscomb G.H., Stovall T.G., and Ling F.W. Non surgical treatment of ectopic pregnancy. New England Journal of Medicine. 2000; 343(18): 1327.

    31. Rosevear S. Bleeding in early pregnancy. In: James D.K., Steer P.J., Weiner C.P., Gonik B. High risk pregnancy management options. 2nd edition, Philadelphia., W.B. Saunders; 1999: 1150.

    32. Olds S.B., Marcia L., and Davidson M.R. Maternal-New born Nursing and womens` health care. 7th edition. United State of America, Prentice Hill; 2004:469, 506, 721, 951.

    33. Ashworth F. Septic abortion. In: Stabile I., Grudzinskas J.G., and Chard T. Spontaneous abortion: Diagnosis and treatment. London, Springer Verlag; 1992: 119.

    34. Anderson N., Wolfhardt J., Christens P., Olsen J., and Mellbye M. Maternal age and fetal loss. British medical Journal. 2000; 320: 1709-1710.
    35. Report. Maternal and child morbidity and mortality in Egypt. Egypt, 2003.
    36. Budd C., and Gardiner M. Paediatrics. Harcourt Brace and company limited; 1999:86-91, 213-221.
    37. Edwards R.K., Locksmith .J., and Duff P. Expanded spectrum antibiotics with preterm, premature rupture of membranes. Obstetrics and gynecology. 2000; 96(1): 63.

    38. Hannah M.E., Ohlssson A., Farine D., et al. Induction of labor compared with expectant management for pre labor rupture of the membranes at term. New England Journal of Medicine. 1996; 3349: 1007.

    39. Chitkara U., and Berkowitz R.L. Multiple gestation. In: Grabbe S.G., Neiebyl G.R., and Simpson J.L. Obstetrics (Normal and problem pregnancies). 4th edition. New York, Churchill Livingstone; 2002: 101-104.

    40. Martin N.G., Shanley S., Butt K., Osborne J., and O`Brein G. Excessive follicular recruitment and growth in mothers of spontaneous dizygotic twins. Acta. Genetic Medicine Gemellol Roma. 1991; 40: 291-301.

    41. Petterson B., Nelson K.B., Waston L., and Stanley F. Twins, triplets, and cerebral palsy in birth in Western Australia in the 1980s. British Medical Journal. 1993; 307: 1239.

    42. Berkowitz R.S., and Goldstein D.P. Gestational trophoblastic disease. Cancer. 1995; 76: 675.

    43. Smith D.B., O`Reilly S.M., and Newlands E.S. Current approaches to diagnosis and treatment of gestational trophoblastic disease. Journal of Ultrasound Medicine. 1993; 12:59.

    44. Crowley P. Corticosteroids prior to preterm delivery. In: Keirse M.J., Renfrew M.J., Neilson J.P., and Crowther C. Pregnancy and childbirth database (database on disc and CD-ROM). Oxford, Update software; 1995.

    45. Cram L.F., Zapata M.I., Joy E.C., and Baker B. Genitourinary infection and their association with preterm labor. American family physician. 2002; 25: 295.
    46. Smith L.G., and Duff P. Infection, antibiotics, and preterm delivery: Seminars in perinatology. 2001; 25: 295.

    47. Lewis G., et al. Report on confidential Enquiries into maternal deaths in the U.K. 1994-1996. London, HMSO; 1998. 48. Harrison K.A., and Rossiter C.E. Maternal mortality. British Journal of Obstetric/ Gynecology. 1985; 5: 102.

    48. Harrison K.A., and Rossiter C.E. Maternal mortality. British Journal of Obstetric/ Gynecology. 1985; 5: 102.

    49. Neilson J.P. Perinatal loss and appropriate fetal surveillance. In: Geijn H.P., and Copray F.J.A. A critical appraisal of fetal surveillance. Amsterdam, Elsevier Science B.V.; 1994: 17.

    50. Hegan R., Benninger H., Chiffings D., Evans S., and French N. Very preterm birth-a regional study-part 1: Maternal and obstetric factors. British Journal of Obstetric/ Gynecology. 1996; 103: 233.

    51. Palmer L., Blair E., Petterson B., and Burton P. Antenatal antecedents of moderate and severe cerebral palsy. Paediatric Perinatal Epidemiology. 1995; 9: 171.

    52. Wolf E.J., Mallozzi A., Rodis J.F., Ean J.F.X., Vintzileos A.M., and Campbell W.A. Placenta previa is not an independent risk factor for a small for gestational age infant. Obstetric/ Gynecology. 1991; 77:707.

    53. Love C.D., and Wallace E.M. Pregnancies complicated by placenta previa. What is appropriate management. British Journal of Obstetric/ Gynecology. 1996; 103: 864.

    54. Wing D.A., Paul R.H., and Millar L.K. Management of the symptomatic placenta previa a randomized controlled trial of inpatient versus outpatient expectant management. American Journal of Obstetric/ Gynecology. 1996; 175: 806-7.

    55. Gaufberg S. Abruptio placentae. English Medical Journal. 2001; 2(3):10.
    56. Pearlman M.D., Tintinalli J.E., and Lorenz R.P. A prospective controlled trial of outcome after trauma during pregnancy. American Journal of Obstetric/ Gynecology. 1990; 162:1502.

    57. Rice J.P., Kay H.H., and Mahony B.S. The clinical significance of uterine leiomyomas in pregnancy. American Journal of Obstetric/ Gynecology. 1989; 160: 1212.

    58. Kramer M.S., Usher R.H., Pollack R., Boyd M., and Usher S. Etiologic determinants of abruption placentae. Obstetric/ Gynecology. 1997; 81: 221.

    59. Miller J.M., Boudereaux M.C., and Regan F.A. A case control study of cocain use in pregnancy. American Journal of Obstetric/ Gynecology. 1990; 162: 1502.
    60. Rasmussen S., Irgens L.M., Bergsjo P., and Dalaker K. Perinatal mortality and case fatality after placental abruption in Norway 1967-1991. Acta Obstetric/ Gynecology Scand. 1996; 75: 229.

    61. Keeling J.W. Macerated stillbirth. In: Keeling J.W. Fetal and neonatal pathology. Berline, Springer-Verlag; 1987: 167.

    62. Fischer R.L., Kuhlman K., Grover J., Montgomery O., and Wapner R.J. Chronic, massive fetomaternal hemorrhage treated with repeated fetal intravascular transfusions. American Journal of Obstetric/ Gynecology. 1990; 162: 203.

    63. Challis J.R.G. Characteristics of parturition. In: Resnick R., Creasy R.K., and Bralow L. Maternal-fetal medicine. 4th edition. Philadelphia, Saunders; 1999: 484.

    64. Demelin L. La Contraction Uterine Etles Discineses Correlative. Paris, Dupont; 1927.

    65. King T. Labor pain in 21st century. Journal of Midwifery and Womens` Health. 2002; 47(2): 68.

    66. Ashe D. From positive to parenthood. Nursing Management. 2000; 31(10):30-31.

    67. Swaim L.S., and Creasy R.K. Fetal assessment and treatment during labor. In: Creasy R.K. Management of labor and delivery. Malden MA, Blackwell; 1997: 164.

    68. Philpott R.H., and Castle W.M. Cervicographs in the management of labour in the primigravida.1.: The alert line for detecting abnormal labour. Journal of Obstetric and Gynecology British Cmmw. 1972; 79:592.

    69. Philpott R.H., and Castle W.M. Cervicographs in the management of labour in the primigravida.2.: The Action line and treatment o abnormal labour. Journal of Obstetric/ Gynecology British Cmmw. 1972; 75: 599.

    70. American College of Obstetricians and Gynecologists(ACOG). Induction of labor (ACOG practice Bulletin No. 10). Washington, Author; 1999.

    71. Rosen T.S., and Batman D.A. Infants of addicted mothers. In: Fanaroff A.A., and Martin R.J. Neonatal-Perinatal medicine: Diseases of the fetus and infants. 7th edition. United State of America, Mosby; 2002: 666.

    72. Johanson R.B., and Menon V. Vacuum extraction versus forceps delivery. In: Neilson J.P., Crowther C., Hodnett E.D., et al. Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Oxford, Update Software; 1997.

    73. Chenoy R., and Johanson R. A randomized prospective study comparing deliver with metal and silicone rubber vacuum extractor cups. British Journal of Obstetric/ Gyencology. 1992; 99: 360.

    74. Sachs B.P., Kobelin C., Castro M.A., and Frigoletto F. Sounding board: The risks of lowering cesarean-delivery rate. New England Journal of Medicine. 1999; 340:55.

    75. Grant A., Penn Z.J., and Steer P.J. Elective or selective cesarean delivery of the small baby? A systematic review of the controlled trials. British Journal Obstetric/ Gynecology. 1996; 103:1197.


    76. Chdha Y.C., Mahmood T.A., Dick M.J. Smith N.C., and Campbell D.M. Breech delivery and epidural analgesia. British Journal Obstetric/ Gynecology. 1992; 99:97.

    77. Dunlop W. The puerperium. Fetal Medicine Review. 1989; 1: 43.

    78. World Health Organization (WHO). The prevention and management of postpartum haemorrhage. Report of a technical working group. Geneva; WHO: 1990.

    79. Anderson H.F., and Hopkins M.p. Postpartum hemorrhage. In: Sciarri J.J. Gynecology and obstetrics. Vol.2. 2002: 7.

    80. Benedetti T.J. Obstetrics hemorrhage. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. Obstetrics: Normal and problem pregnancies. 4th edition. 2002: 503-538.

    81. Roberts W.E. Emergent obstetric management of postpartum hemorrhage. Obstetric/ Gynecology Clinical in North of America. 1995; 22: 283.

    82. Department of Health. Report on Confidential Enquiries into maternal deaths in the United Kingdom 1988-1990. London, HMSO; 1994.

    83. Toppenberg K.S., and Black W.A. Uterine rupture: What family physicians need to know. American family physician. 2002; 66(3):826.

    84. Alexander J.D., and Schneider F.D. Vaginal bleeding associated with pregnancy. Primary care. 2000; 27(1): 140.

    85. Gilbert E.S., and Harman J.S. Manual of high risk pregnancy and delivery. 3rd edition. United State of America, Mosby; 2003: 201-205.

    86. Cash J.C., and Glass C.A. Family practice guidelines. Philadelphia, Lippincott; 2000: 8-11.

    87. Baxley E.G. Postpartum biomedical concerns. Section B postpartum endometritis. In: Ratcliffe S.D., Baxley E.G., Byrd J.E., and Sakornbut E.L. Family practice obstetrics. 2nd edition. Philadelphia, Hanley and Belfus; 2001: 602-604.
    88. Bowes W.A., and Katz V.L. Obstetrics: Normal and problem pregnancies. 4th edition. New York, Churchill Livingstone; 2002: 712-716.

    89. Meighan M., Davis M.W., Thomas S.P., and Droppleman P.G. Living with postpartum depression: The father`s perspective. American Journal of Maternal child Nursing. 2000; 24(4): 202-204.

    90. Gjerdinger D., and Byrd J.E. Postpartum psychosocial concerns. In: Ratcliff S.D., Baxley E.G., Byrd J.E., and Sakornbut E.L. Family practice obstetrics.2nd edition. Philadelphia, Hanley and Belfus; 2001: 626.

    91. Report on confidential enquiries into maternal death in United Kingdom. 2004: 9-215.

    92. Cynthia J., and Berg M.D. Centers for disease control and prevention. Atlanta.
    128. Begaud B. Dictionary of pharmacoepidemiolog. New York, John Wiley and Sons; 2000: 90.

    93. Blackburn S.T. Maternal, fetal and neonatal physiology: A clinical perspective.2nd edition. United State of America, Saunders; 2003: 605.

    94. Fanaroff A.A., and Martin R.J. Neonatal-Perinatal Medicine Diseases of the fetuses and infants. 5th edition. Vol.2. United State of America, Mosby-year book; 1992: 835.

    95. Edwards M.S. Postnatal bacterial infection. In: Fanaroff A.A., and Martin R.J. Neonatal-Perinatal medicine: Diseases of the fetus and infant. 7th edition. Vol.2. United State of America, Mobsy; 2002:730.

    96. de Swiet M. Medical Disorders in Obstetric Practice. Oxford, Blackwell Science Ltd; 1995: 607.

    97. James F., Joann G., and David L. Epidemiology, biostatistics, and preventive medicine. United State Of America, Saunders;1996: 104-106.

    98. David E., and Stolley P.D. Foundation of epidemiology. Third edition. New York, Oxford University Press; 1994: 172.

    99. Dawson B., and Robert G. Basic and clinical biostatistics. Fourth edition. A lange medical book. MCGraw-Hill Companies; 2004: 297.

    100. Cassens B.J. Preventive medicine and public health. Second edition. United State of America, Library of Congress; 1992:35.

    101. Naylor C.D. Two cheers for meta analysis: Problem and apportunities in aggregating results of clinical trials. Canadian Medical Journal. 1988; 138: 891.

    102. Lipsey M.W., Wilson D.B. Practical meta analysis applied social research methods series. Thousand Oaks, CA. Sage publication. 2001; Vol.49.

    103. Jenicek M. Foundations of evidence based medicine. London, The Parthenon publishing group; 2003: 303-320.

    104. Zautra A., and Hempel A. Subjective wellbeing and physical health: A narrative literature review with suggestions for future research. International Journal of Aging Human Development. 1984; 19:96.

    105. Cook D.J., Mulrow C.D., and Haynes R.B. Systematic reviews: Synthesis of best evidence for clinical decisions. Annal Internal Medicine. 1977; 126: 377.

    106. Light R.J., and Smith P.V. A ccumulating evidence: Procedures for resolving contradictions among different research studies. Harvard Educational Review. 1971; 41: 459.

    107. Hedges L.V., and Olkin I. Vote counting methods in research synthesis. Psychological Bull. 1980; 88: 365.

    108. George L.K., Landerman R. Health and subjective wellbeing: A replicated secondary data analysis. International Journal of Aging Human Development. 1984; 19: 136.

    109. Kassirer J.P. Clinical trials and meta analysis: What do they do for us?. New England Journal of Medicine. 1992; 327: 274.
    110.Dickersin K., and Berline J.A. Meta analysis: State of the science. Epidemiological Review. 1992; 14:160.

    111. Lau J., Ioannidis J.P.A., and Schmid C.H. Quantitative synthesis in systematic reviews. Annal Internal Medicine. 1997; 127: 820.

    112. Mulrow C.D., Cook D.J., and Davidoff F. Systematic reviews: Critical links in the great chain of evidence. Annal Internal Medicine. 1997; 126: 390.

    113. MCQuay H.J., and Moore R.A. Using numerical results from systematic reviews in clinical practice. Annal Internal Medicine. 1997; 126: 712.

    114. Badgett R.C., O`Keefe M., and Henderson M.C. Using systematic reviews in clinical education. Annal Internal Medicine. 1997; 126: 886.

    115. Introduction to meta analysis and systemic reviews. Report, 2000.


    116. Hampton J.R. The end of medical history?. Journal Roy. Collection Physics London. 1998; 147: 717.

    117. Goldman L., and Feinstein A.R. Anticoagulants and myocardial infarction: The problems of pooling, drowning, and floating. Annal Internal Medicine. 1989;90: 93.

    118. Naylor C.D. Two cheers for meta analysis: Problems and apportunities in aggr-egating results of clinical trials. Canadian Medical Assistant Journal. 1988; 138:891.

    119. Goodman S.N. Have you ever meta analysis you didn`t like?. Annal International Medicine. 1991; 114: 891.

    120. Gerberg Z., and Horwitz R.I. Resolving conflicting clinical trials: Guidelines for meta analysis. Journal of Clinical Epidemiology. 1988; 41: 503.
    121. Katz D.L. Epidemiology, biostatistics, and preventive medicine review. United State Of America, Saunders;1997:52.

    22. Greenland S. Invited commentary: A critical look at some popular meta analytic methods. American Journal of Epidemiology. 1994; 140: 290.

    123. Jenicek M. Meta analysis in medicine. Evaluation and synthesis clinical and epidemiological information. Paris, E. Dis. E.M. and Maloine; 1987.

    124. Gallagher E.J. Systematic reviews: A logical methodological extension of evidence based medicine. Academic Emergency Medicine. 1999; 6: 1256.

    125. King J.C. The risk of maternal nutritional depletion and poor outcome increases in early or closely spaced pregnancies. Journal of Nutrition. 2003 May; 133(5 suppl 2): 1735.

    126. Mahony R., and O`Herlihy c. Thirty year trends in a large Irish obstetrics cohort. Irish Medical Journal. 2003 March; 96(3): 86.

    127. Wasunna A., and Mohammed K. Low birth weight babies sociodemographic and obstetric characteristics of adolescent mothers at Kenyatta National Hospital, Nairobi. East Africa Medical Journal. 2002 October; 79(10): 543.

    128. Kirchengast S., and Hartmann B. Advanced maternal age is not only associated with newborn somatometrics but also with the mode of delivery. Annal Human Biology. 2003 January-February; 30(1): 1.

    129. Donoso E., and Villarroel L. Reproductive risk of women over 40 years old. Review of Medicine and Child health. 2003 January; 131(1): 55.
    130. Olatunji A.O., and Sule-Odu A.O. Maternal Mortality at Sagamu, Nigeria- a ten year review (1988-1997). Niger Postgraduat Medical Journal. 2001 March; 8(1): 12.

    131. Williams K.P., and Wilson S. The impact of parity on incidence of HELLP syndrome and small for gestational age infants in hypertensive pregnant women. Journal of Obstetric/ Gynecology in Canada. 2002 June; 24(6): 485.

    132. Perren S., Von-wyl A., Simoni H., Stadlmayr W., Burgin D., and Von-Klitizing K. Parental psyhopathology, marital quality, and the transition to parenthood. American Journal Orthopsychiatry. 2003 January; 73(1): 55.

    133.US Conferences of Mayors. Hanger and homlessness up sharply in a major United States cities. New York, Authors: 2001.

    134. National Coalition for homlessness (NCH fact sheet No.8). Retrievered on September 16, 2002 from http://nch. Ari. Net/ domestic. html.

    135. Senat M.V., Ancel P.Y., Bouvier-Colle M.H., and Breart G. How does multiple pregnancy affect maternal mortality and morbidity?. Clinical Obstetrics and gynecology. 1998; 41: 79.

    136. Jacquemyn Y., Martens G., Ruyssinck G., Michiels I., and Van-Overmeire B. A matched cohort comparison of the outcome of twin versus singleton pregnancies in Flanders, Belgium. Twin Res.2003 Feb; 6(1): 10.

    137. Francois K., Johnson J.M., and Harris C. Is placenta previa more common in multiple gestations? American Journal of Obstetric/ Gynecology. 2003 May; 188(5): 1226.

    138. Lynch A., McDuffie R., Stephens J., Murphy J., Farber K., and Orleaus M. The contribution of assisted conception chorionicity and other risk factors to very low birth weight twin cohort. British Journal of Obstetric/Gynecology. 2003 April; 110(4): 405.

    139. Misic Z., Krezo S., Mamic I., et al. Perinatal care in Livno immediately after the war from 1995-1999. Godine. Medicine Arh. 2003; 57(1):39.

    140. Boulet S.L., Alexander G.R., Salihu H.M., and Pass M. Macrosomic births in the United State: Determinants, outcomes, and proposed grades of risk. American Journal of Obstetric Gynecology. 2003 May; 188(5): 1372.

    141. Kyomuhendo G.B. Low use of rural maternity services in Uganda: Impact of women`s status, traditional beliefs and limited resources. Reproductive Health Matters. 2003 May; 11(21): 16.

    142. Safdar S., Inam S.N., Omair A., and Ahmed S.T. Maternal health care in a rural area of Pakistan. Journal of Park. Medicine.

    143. Sogaard M., and Vested-Jakobsen A. Consanguinity and congenital abnormalities. Ugeskr-Laeger. 2003 April 28; 165(18): 1851.

    144. Saad F.A., and Jauniax E. Recurrent early pregnancy loss and consanguinity. Reproductive Biomedical Online. 2002 September-October; 5(2): 167.

    145. Al-Bustan S.A., El-Zawahri M.M., Al-Adsani A.M., et al. Epidemiological and genetic study of 121 cases of oral clefts in Kuwait. Orthopaedic Craniofacacial Res. 2002 August; 5(3): 154.

    146.Anonymous. Birth spacing: Three to five save lives. Population Reproductive Life.2002 Summer;13: 1-2.

    147. Agustin Conde-Agudelo et al. Birth spacing and of adverse perinatal outcomes. Journal of American Medical Association. 2006; 295(15): 1809.

    148. Finer L.B., Henshaw S.H. Abortion incidence and services in the United States in 2000. Perspective Sexual and Reproductive Health. 2003 January-February; 35(1):6.

    149. Talukder S.I., and Haque A. Frequency of abortion in different seasons and age group. Mymensingh Medical Journal. 2003 January; 12(1): 8.

    150. Qublan H.S., Jumaian N., Au Salem A., Hamadelol F.Y., Mashagbeh M., and Abdel Ghani F. Journal of Obstetric/ Gynecology. 2002 May; 22(3): 296.

    151. Diejomaoh M.F., Al-Azemi M., Jirous J., et al. The aetiology and pattern of recurrent pregnancy loss. Journal Obstetric/ Gynecology. 2002 January; 22(1): 58.

    152. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy related mortality surveillance United States 1991-1999. MMWR. Surveillance Summary. 2003 February 21; 52(2): 1

    153. Harvey S., Rach D., Stainton M.C., Jarrell J., and Brant R. Evaluation of satisfaction with midwifery care. Midwifery. 2002 December; 18(4): 260.

    154. Nasheit N.A. Perinatal and neonatal mortality and morbidity in Iraq. Journal of Maternal, Fetal and Neonatal Medicine.2003 January; 13(1):64.

    155. Neggers Y., and Goldenberg R.L. Some thoughts on body mass index, micronutrient intake and pregnancy outcome. Journal of Nutrition. 2003 May; 133(5 suppl 2): 1737s.

    156. Garland S.M., Ni-Chuileannain F., Satzke C., and Robins-Browne R. Mechanisms organisms and markers of infection in pregnancy. Journal of Reproductive Immunology. 2002 October-November; 57(1-2): 169.

    157. Ananth C.V., Smulian J.C., and Vintzileos A.M. The effect of placenta previa on neonatal mortality: A population based study in the United States 1989-1997. American Journal of Obstetric/ Gynecology. 2003 May; 188(5): 1299.

    158. Treger M., Hallak M., Silberstein T., Friger M., Katz M., and Mazor M. Post term pregnancy: Should induction of labor be considered before 42 weeks?. Journal of Maternal, Fetal and Neonatal Medicine. 2002 January; 11(1): 50.

    159. Maghoma J., and Buchmann E.J. Maternal and fetal risks associated with prolonged latent phase of labor. Journal of Obstetric / Gynaecology. 2002 January; 22(1): 16.

    160. Kaufman J., and Jing F. Privatisation of health services and the reproductive health of rural Chinese women. Reproductive Health Matters. 2002 November; 10(20): 108.
    161. Janssen P.A., Lee S.K., Ryan E.R., and Saxell L. An evaluation of process and protocols for planned home birth attended by regulated midwives in British Columbia. Journal of Midwifery Women Health. 2003 March-April; 48(2): 138.

    162. Goldman N., and Glei D.A. Evaluation of midwifery care: Results from a survey in rural Guatemala. Social Scientific Medicine. 2003 February; 56(4): 685.

    163. Sanchez-Ramos L., and Hsieh E. Pharmacologic methods for cervical ripenin and labor induction. Current Women. Health Report. 2003 February ; 3(1): 55.

    164. Ben-Aissia N., Gara M.F., Yazidi M., Battar S., and Sadfi A. Delivery by forceps: Indications and maternofetal morbidity. Tunis Medicine. 2003 March; 81(3): 180.

    165. Shihadeh A., and Al-Najdawi W. Forceps or vacuum extraction: A comparison of maternal and neonatal morbidity. East Mediterranean Health Journal. 2001 January-March; 7(1-2): 106.

    166. Bergholt T., Stenderup J.K., Vedsted-Jakobsen A., Helm P., and Lenstrup C. Intraoperative surgical complication during C/S: An observational study of the incidence and risk factors. Acta. Obstetric/ Gynecology in Scand. 2003 March; 82(3): 251.

    167. Freeman R.K. Problems with intrapartum fetal heart rate monitoring interpretation and patient management. Obstetric/ Gynecology. 2002 October; 100(4): 813.

    168. Williams K.P., and Galerneau F. Intrapartum fetal heart rate patterns in the prediction of neonatal academia. American Journal of Obstetric/ Gynecology. 2003 March; 188(3): 820.

    169. Carbonne B., Gougeul V., and Fekih K.M. Intrapartum fetal monitoring. Journal of Gynecology/ Obstetric and Biological Reproduction.(Paris). 2003 February; 32: 1579.

    170. Pattinson R.C., Howarth G.R., Macdonald A.P., Makin J.D., and Funk M. Aggressive or expectant management of labour: A randomized clinical trial. British Journal of Obstetric/Gynecology. 2003 May; 110(5): 457.
    171. Weiner C.P. Fetal hemolytic disease. In: James D.K., Steer P.J., Weiner C.P., and Gonik. High risk pregnancy management options. 2nd edition. Philadelphia, Saunders W.B.; 1999.

    172. American College of Obstetricians and gynecologists (ACOG). Prevention of RhD alloimmunization (ACOG Practice Bulletin No.4). Washington DC, Author; 1999c.

    173. Chakraborty N., Islam M.A., Chowdhury R.I., and Bari W. Analysis of antepartum maternal morbidity in rural Bangladesh. Australian Journal of Rural Health. 2003 January; 11(1): 22.

    174. Buchmann E.J., Pattinson R.C., and Nyathikazi N. Intrapartum related birth asphyxia in South Africa lessons from the first national perinatal care survey. South Africa Medical Journal. 2002 November; 92(11):897.

    175. French M.R., Barr S.I., and Levy Milne R. Folate intake and awareness of folate to prevent neural tube defect: A survey of women living in Vancouver, Canada. Journal of American Diet Association. 2003 February; 103(2): 181.

    176. Barash J.H., and Weinstein L.C. Preconception and prenatal care. Primary Care. 2002 September; 29(3): 519.

    177. Correa A., Botto L., Liu Y., Mulinare J. and Erickson J.D. Do Multivitamin supplements attenuate the risk for diabetes associated birth defects? Paediatrics. 2003 May; 111(5 part 2): 1146.

    178. Duley L., and Henderson-Smart D.J. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Systemic Review. 2002; 4: CD 001449

    179. Crane J, Armson A., Brunner M., et al. Antenatal corticosteroid therapy for fetal maturation. Journal of Obstetric/ Gynecology in Canada. 2003 January; 25(1): 45
    180. Foong S.C., and Pollard J.K. Eclampsia in Southern Alberta: Is there a role for seizure prophylaxis in all women with gestational hypertension? Journal of Obstetric/ Gynecology in Canada 2003 May; 25(5): 385.

    181. Malhorta M., Sharma J.B., Barta S., Sharma S., Murthy N.S., and Arora R. Maternal and perinatal outcome in varying degrees of anemia. International Journal of Gynaecology/ Obstetrics. 2002 November; 79(2): 93.

    182. Beye M.D., Diouf E., Kane O., et al. Intensive care managements of 28 patient with sever eclampsia in a tropical African setting. Annal French Anesthesia Reanim. 2003 January; 22(1): 25.

    183. Steel J.M., Johnstone F.D., Hepburn D.A., and Smith S.A.F. Can pre pregnancy care of diabetic women reduce the risk of abnormal babies?. British Medical Journal 1990; 301: 1070.

    184. Aisien A.O., Lawson J.O., and Adebayo A.A. A five year appraisal of cesarean section in Northern Nigeria University Teaching Hospital. Niger Postgraduate Medical Journal. 2002 September; 9(3): 146.

    185. Kinzler W.L., Ananth C.V., Smulian J.C., and Vintzileos A.M. The effects of labor on infant mortality among small for gestational age infants in the United State of. America. Journal of Maternal, Fetal and Neonatal Medicine.2002 September; 12(3): 201.

    186. Bari W., Chowdhury R.I., Chakraborty N., and Akhter H.A. The differentials and determinants of perinatal mortality in rural Banghladesh. European Journal of Contraception and Reproductive Health Care. 2002 December; 7(4): 216.

    187. Sheiner E., Shoham-Vardi I., Hallak M.,et al. Placental abruption in term pregnancies clinical significance and obstetric risk factors. Journal of Maternal, Fetal and Neonatal Medicine. 2003 January; 13(1):45.

    188. Berg C.J, Chang J., Callaghan W.M., and Whitehead S.J. Pregnancy related mortality in the United States 1991-1997. Obstetric/ Gynaecology. 2003 February; 101(2): 289.

    189.Gaym A. A review of maternal mortality at Jimma Hospital, Southwestern Ethiopia. Ethiopian Journal of Health Development. 2000; 14(2): 215-223.

    190. Sloan N.L., Langer A., Hernandez B., Romero M., and Winikoff B. The etiology of maternal mortality in developing countries: What do verbal autopsies tell us? Bulletin of the World Health Organization. 2001; 79: 805-810.

Appendix I

Name:

Age: Number:

Occupation:

Residence:    Urban / Rural

Marital state:  Married / Divorce / Widow / Separated

Educational level:
Illiterate / Primary education / Secondary education / Higher education

Socio economic level:  Low / Middle / High

Blood group and Rh:

Husband age:

Husband occupation:

Husband blood group and Rh:

Are they relative?      Yes / No

Degree of   relation:   First degree / Second degree

**Antenatal    care:

Gravida / Para / Abortion / LMP / EDD

No. of current pregnancy:

If pregnancy:    Single / Multiple

Method of pregnancy diagnosis:  Urine / U/S / Non

Gestational  age:

Trimester: 1st  / 2nd / 3rd       

Site of ANC:  Private / PHCC / Both

Time of  1st  visit:

Frequency of visit:

Type of ANC: Adequate / Not adequate

Immunization:

High risk group:    Yes / No

Cause of risk:

Any  investigation done during pregnancy:

Radiation exposure:  Yes / No

Time of it:

Drugs taken during pregnancy:

 Any complication:

**Abortion & still birth:

Gestational age:

Trimester:     1st  / 2nd / 3rd

Type of abortion:

Cause of it:

Any complication:

**Natal care:

Date of delivery:

Labour: Full term pregnancy / Preterm / Post term

Site of delivery: Hospital / Home

If home delivery by:

Registered midwife / Not registered  midwife / Not aided at all

Duration of labour:                                            

Type of delivery: NVD / C/S  / NVD with induction / Instrumental

If C/S:  Elective / Emergency

Why C/S?

Complication of C/S:

Complication of NVD:

Type of fetal monitoring during labour:

FH each 1/2h  /  Partogram  / PH estimation

Sex of baby:  Male / Female

Weight of baby:

If baby:  Normal  / Abnormal

Abnormal due to congenital anomalies: Yes / No

What’s the anomaly? :

Abnormality due to complication of labour:

RDS  /  Fracture  /  Cerebral palsy  / Intracranial haemorrhage                                                                      

**PNC:

1st   visit time post termination:

Immunization:

Prolonged lochia:  Yes  / No   

Complication:    Early / Late

Early:  PPH /  Sudden post partum collapse

PPH:  Primary /  Secondary

Primary PPH:  Uterine inertia / Genital tract injury                 

Secondary PPH: Infection  / Retained placental piece

Sudden post partum collapse: Internal bleeding / Embolism /  Eclamptic fit

Late complication: Mastitis / UTI /  Wound infection / Purperial sepsis  

##Past obstetrical history:

No. of previous pregnancies:

History of multiple pregnancy:

Mode of delivery: NVD /  C/S  / No. of C/S

ANC & PNC in previous pregnancies:  Adequate /  Not adequate

Complications of previous pregnancies:

Outcome (fetus): Normal / Abnormal / Death

Any admission to neonatal care unit:  Yes / No

Purperium of previous labour:

Spacing:  >2 years / <2years

Contraception use: Yes / No

Type of contraception: Natural  / Hormonal  / IUCD / Barrier

History of infertility: Yes / No

Infertility:  Primary  /  Secondary

##Menstrual  history:

Menarche:

Frequency:

Dysmenorrhea:  Yes / No

##Drug history:

1-Preconceptional  preventive drugs: Folic acid / Aspirin

2-Specific diseases:  Hypertension / DM  /  Others

3-Regarding pregnancy: Tonics  / Others

##Medical history:

##Surgical history:

##Social history:  Smoking  / Alcoholic  /  Drug addiction

##Family history:

 
Appendix II -   High Risk Evaluation Form(15)

*Reproductive history

Age:   <16 years

           16-35

            >35

4.0>1
4.0>0
4.0>2

Parity:t;5

4.0>1
4.0>0
4.0>2

Two or more abortion or history of infertility

4.0>1

Postpartum bleeding or manual removal of placenta.

4.0>1
4.0>2
Column Total

*Medical or surgical associated condition

Previous gynecological surgery.

4.0>1

Chronic renal diseases`

4.0>1

Gestational diabetes A.

4.0>1

Class B or greater diabetes.

4.0>3

Cardiac diseases.

4.0>3

Other significant medical disorder (1-3) according to severity.

4.0>1-3
Column Total  

*Present pregnancy

Bleeding:   <20 week

                    >20 week

4.0>1
4.0>3

Anemia (<10 g/l)

4.0>1

Postmaturity.

4.0>1

Hypertension.

4.0>2

PROM.

4.0>2

Polyhydramnios.

4.0>2

I.U.G.R.

4.0>3

Multiple pregnancy.

4.0>3

Breech or malpresentation.

4.0>3

Rh-isoimmunization.

4.0>3
Column Total  

*Total Score  (summation of 3 columns).

   -Low risk                  0-2

   -High risk                 3-6

   -Sever risk                7 or more   

 


Disclaimer
l © Copyright 2007 medi+WORLD International Pty. Ltd.